Mechanisms of translational regulation in the pancreatic β cell stress response by Templin, Andrew Thomas
MECHANISMS OF TRANSLATIONAL REGULATION IN THE PANCREATIC  
 CELL STRESS RESPONSE 
 
 
 
 
 
 
 
Andrew Thomas Templin 
 
 
 
 
 
 
 
 
 
 
 
Submitted to the faculty of the University Graduate School 
in partial fulfillment of the requirements 
for the degree 
Doctor of Philosophy 
in the Department of Cellular and Integrative Physiology, 
Indiana University 
 
August 2014 
  
! ii 
Accepted by the Graduate Faculty of Indiana University, in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
_____________________________________ 
Raghavendra G Mirmira, MD, PhD, Chair 
 
 
 
 
_____________________________________ 
Richard N. Day, PhD 
Doctoral Committee 
 
 
 
_____________________________________ 
Patrick T. Fueger, PhD 
 
 
 
 
_____________________________________ 
Maureen A. Harrington, PhD 
July 21, 2014 
 
 
 
_____________________________________ 
Ronald C. Wek, PhD 
 
 
 
 
 iii 
DEDICATION 
 
 I dedicate this to my family, without whose loving support, motivation, and 
friendship this work would not have been possible.  
 
  
 iv
ACKNOWLEDGEMENTS 
  
 The work described here is the product of an incredible amount of 
commitment, hard work, and intellect from a group of dedicated diabetes 
researchers.  First and foremost, I would like to thank my mentor Dr. Raghu 
Mirmira.  Raghu’s valuable mentorship has provided an outstanding example for 
me to emulate as I continue to mature as a research scientist.  None of this work 
would have been possible without Raghu’s support.  Additionally, I would like to 
thank my thesis committee, Dr. Rich Day, Dr. Patrick Fueger, Dr. Maureen 
Harrington, and Dr. Ron Wek.  The committee’s knowledge and guidance has 
been invaluable throughout my graduate school experience.  Dr. Bernhard Maier 
has been a great friend and a valued scientific resource.  Dr. Sarah Tersey’s 
animal physiology skill was critical to many of these studies.  I would like to thank 
Dr. Teressa Mastracci for her helpful suggestions and developmental biology 
expertise.  I have had the great fortune of working with a number of 
accomplished post-doctoral researchers, among them Dr. Masayuki Hatanaka, 
Dr. Yurika Nishiki, and Dr. Stephanie Colvin.  I would also like to thank my fellow 
graduate student in the Mirmira laboratory, Aarthi Maganti, for her support and 
friendship throughout this process.  Many thanks to Ms. Natalie Stull and Ms. 
Kara Benninger, whose expert islet isolation skills contributed to many of these 
studies.  I would also like to extend thanks to each and every member of the 
Basic Diabetes Research Group; it has been a true pleasure to work with you.  I 
would like to thank my family, Dr. Thomas Templin, Sarah Templin, and Kate 
 v 
Stahl, and my girlfriend, Rachel Graham.  Without your support this would not 
have been possible.  Thank you for your loving encouragement, motivation, and 
inspiration.  
 vi
Andrew Thomas Templin 
MECHANISMS OF TRANSLATIONAL REGULATION IN THE PANCREATIC  
 CELL STRESS RESPONSE 
 
 The islet  cell is unique in its ability to synthesize and secrete insulin for 
use in the body.  A number of factors including proinflammatory cytokines, free 
fatty acids, and islet amyloid are known to cause  cell stress.  These factors 
lead to lipotoxic, inflammatory, and ER stress in the  cell, contributing to  cell 
dysfunction and death, and diabetes.  While transcriptional responses to  cell 
stress are well appreciated, relatively little is known regarding translational 
responses in the stressed  cell.  To study translation, I established conditions in 
vitro with MIN6 cells and mouse islets that mimicked UPR conditions seen in 
diabetes.  Cell extracts were then subjected to polyribosome profiling to monitor 
changes to mRNA occupancy by ribosomes.  Chronic exposure of  cells to 
proinflammatory cytokines (IL-1, TNF-, IFN-), or to the saturated free fatty 
acid palmitate, led to changes in global  cell translation consistent with 
attenuation of translation initiation, which is a hallmark of ER stress.  In addition 
to changes in global translation, I observed transcript specific regulation of 
ribosomal occupancy in  cells.  Similar to other privileged mRNAs (Atf4, Chop), 
Pdx1 mRNA remained partitioned in actively translating polyribosomes during the 
UPR, whereas the mRNA encoding a proinsulin processing enzyme (Cpe) 
partitioned into inactively translating monoribosomes.  Bicistronic luciferase 
reporter analyses revealed that the distal portion of the 5’ untranslated region of 
 vii 
mouse Pdx1 (between bp –105 to –280) contained elements that promoted 
translation under both normal and UPR conditions.  In contrast to regulation of 
translation initiation, deoxyhypusine synthase (DHS) and eukaryotic translation 
initiation factor 5A (eIF5A) are required for efficient translation elongation of 
specific stress relevant messages in the  cell including Nos2.  Further, p38 
signaling appears to promote translational elongation via DHS in the islet  cell.  
Together, these data represent new insights into stress induced translational 
regulation in the  cell.  Mechanisms of differential mRNA translation in response 
to  cell stress may play a key role in maintenance of islet  cell function in the 
setting of diabetes. 
 
 
Raghavendra G Mirmira, MD, PhD, Chair 
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CHAPTER 1 
Introduction 
 
1.1 THE ISLET  CELL 
 The pancreatic islet  cell is unique in its ability to synthesize and secrete 
insulin.  Insulin is a highly conserved 51 amino acid peptide hormone that is 
required for the cellular uptake of glucose into adipose and muscle tissue, and for 
the suppression of glucose output by the liver.  Insulin is synthesized by the  cell 
as a preprohomone, which is subsequently proteolytically processed in the 
endoplasmic reticulum (ER), Golgi, and secretory granules to the mature peptide, 
consisting of two polypeptide chains (1).  Systemic resistance to the action of 
insulin, as well as defects in the secretion of insulin by islet  cells are risk factors 
for the development of diabetes (Fig. 1).  Failure of the  cell to produce sufficient 
insulin to meet demand is a common feature of both type 1 and type 2 diabetes, 
and is the most important determinant of progression from the pre-diabetic state 
to frank diabetes (2).  As such, research aimed at preserving  cell mass and 
function may offer new therapies for treatment of diabetes.     
 
A. Mechanisms of Glucose Stimulated Insulin Secretion 
  cell insulin secretion is carried out by mechanisms unique to the cell 
type.  Insulin secretion requires a stimulus-secretion coupling mechanism known 
as glucose-stimulated insulin secretion (GSIS).  When glucose concentrations in 
the blood rise (for example following a meal), glucose molecules move into the  
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cell via facilitated diffusion through glucose transporter type 2 (GLUT2).  
Importantly, GLUT2 activity is not dependent upon insulin (3).  Next, the high Km 
enzyme glucokinase phosphorylates glucose, forming glucose-6-phosphate (Fig. 
2).  Glucokinase is the rate-limiting enzyme in glucose metabolism, thereby 
functioning as a glucose sensor and regulator of insulin secretion (4).  Glycolysis 
leads to an increase in intracellular ATP, and subsequent closing of ATP 
sensitive potassium channels in the  cell plasma membrane (5).  This results in 
membrane depolarization, and opening of voltage gated Ca2+ channels. The 
subsequent increase in cytosolic Ca2+ concentration causes insulin-containing 
vesicles to fuse to the plasma membrane (Fig. 2).  In this manner, the  cell 
directs exocytosis of insulin in appropriate amounts to dispose of blood glucose 
and suppress hepatic glucose output.   
 Although the main stimulus for insulin release is an elevation in blood 
glucose, several other factors can trigger its release, including amino acids, fatty 
acids, hormones, and neuronal stimuli (3).  In addition to its role in GSIS, glucose 
may also affect insulin production by enhancing stabilization and translational 
efficiency of preproinsulin mRNA (6,7).   
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Figure 1:  Pathophysiology of diabetes mellitus.  Insulin secreted from 
pancreatic  cells acts to regulate blood glucose concentration.  Insulin allows 
glucose uptake in adipose tissue and skeletal muscle, while inhibiting hepatic 
glucose output.  In the setting of diabetes, a number of factors including genetic 
predisposition, cytokines, free fatty acids, and hyperglycemia initiate insulin 
resistance and/or repress  cell function, leading to impairments in blood glucose 
homeostasis. 
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Figure 2: Glucose-stimulated insulin secretion.  A schematic representation 
of GSIS in the pancreatic  cell.  Glucose enters the  cell via facilitated diffusion 
through GLUT2 transporters.  Glucokinase catalyzes the rate-limiting step in 
GSIS, phosphorylation of glucose to glucose-6-phosphate.  This leads to further 
metabolism through glycolysis and the citric acid cycle to generate ATP.  
Increased intracellular ATP concentration closes ATP-sensitive K+ channels, 
leading to membrane depolarization and opening of voltage-gated Ca2+ 
channels.  Subsequent influx of Ca2+ ions leads to secretion of insulin containing 
granules via exocytosis, and normalization of blood glucose. 
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B. Transcriptional Regulation in  Cell Development 
 In an effort to promote  cell insulin secretion and/or derive new  cells, 
recent research has focused on understanding the mechanisms directing 
embryonic  cell development and maintenance of the mature  cell phenotype.  
These studies have identified a number of  cell transcription factors critical to 
these processes.  These transcription factors are DNA binding proteins that 
engage consensus sequences in the promoter region of certain genes, thereby 
regulating transcription of those genes.  
 The generation of mature  cells from multi-potent progenitors requires 
spatial and temporal regulation of transcription factor expression.  Development 
of the  expressionlls rat least three essential steps: 1) commitment of endodermal 
progenitor cells to pancreatic cell fate, 2) differentiation of pancreatic endoderm 
to endocrine precursors, and 3) commitment of endocrine precursors to  cell 
fate. Each of these developmental steps is regulated by transcription factor 
expression (8). A recent study shows these developmental steps can be 
recapitulated through adenovirus-mediated overexpression of just three factors 
(Pdx1, Neurog3, MafA) in non- cell types in the pancreas, with the resultant 
“reprogrammed” cells phenotypically indistinguishable from mature  cells (9).   
 Pdx1 is perhaps the most critical protein in pancreas and tein 
indevelopment.  Pdx1 is expressed in the early endoderm that is destined to form 
the pancreas, distal stomach, and duodenum.  In the adult, Pdx1 expression is 
restricted largely to  cells, although low-level expression is observed in  cells of 
the islet, and acinar and duct cells of the pancreas (10).  Absence or inactivation 
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of Pdx1, as observed in Pdx1-/- mice and in humans with PDX1-/- mutations, 
results in near-complete pancreatic agenesis (11,12).  Moreover, Pdx1+/-  mice 
(MODY4, see Chapter 1.2A) exhibit glucose intolerance as a result of impaired 
insulin release (13).  These data indicate a central importance of Pdx1 in 
pancreas and  cell development. 
Neurog3 is a basic helix-loop-helix transcription factor that directs 
pancreatic progenitor cells towards the endocrine fate (14).  Neurog3-/- mice 
have normal exocrine and ductal tissue, but are completely devoid of endocrine 
tissue (15).  Conversely, ectopic Neurog3 expression throughout the entire 
forming pancreatic bud (via Pdx1 promoter-driven transgene) results in near 
complete conversion of the pancreas into endocrine tissue, consisting mostly of 
glucagon-producing  cells (16,17).  Conversion of endocrine progenitors toward 
the Ccell fate requires additional transcription factors.  The Maf leucine-zipper 
containing transcription factors MafA and MafB direct the concluding steps of  
cell development.  MafA-/- and MafB-/- mice develop morphologically normal 
islets.  However, genetic deficiency of either MafA or MafB results in a reduction 
in the number of  cells present (18–20).  Other transcription factors including 
Pax4, Nkx6.1, and Nkx2.2 are also involved in directing final  cell differentiation 
(21–23).  Together, these transcription factors enable development of functional 
islet  cells. 
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C. Transcriptional Regulation in  Cell Function 
 In addition to its role in pancreas and  cell development, Pdx1 is 
essential for maintenance of  cell identity and function.  In the mature  cell, 
Pdx1 has been shown to regulate genes involved in preproinsulin transcription 
and secretion, including preproinsulin itself, Glut2, Gck (encoding glucokinase), 
MafA, Nkx6.1, and its own gene (Pdx1) (24–28).  Deletion of Pdx1 in the  cell 
results in altered islet morphology, decreased insulin, islet amyloid polypeptide 
(IAPP), and GLUT2 production, impaired GSIS, and glucose intolerance (24,29).  
Chromatin immunoprecipitation and promoter microarray studies have revealed a 
number of additional genes putatively regulated by Pdx1, including those 
concerned with cell cycle, cell survival, exocytosis, and energy sensing (30).  
 Recently, Pdx1 has been implicated in maintenance of  cell function in 
the setting of diabetes.  Insulin resistance induced  cell compensatory 
hyperplasia (discussed in Chapter 1.2D) is attenuated in Pdx1+/- mouse models  
(31).  Additionally, Pdx1 heterozygosity predisposes mice to  cell ER stress and 
apoptosis (32).  Finally, loss of Pdx1 in the adult mouse using a tet-off inducible 
gene repression system results in progressive  cell dysfunction, reduced insulin 
and GLUT2 production, and hyperglycemia (33).   
 Studies indicate Pdx1 is essential for  cell health, inviting speculation 
about whether increasing Pdx1 expression could lead to preservation or 
enhancement of functional  cell mass.  Indeed, overexpression of Pdx1 in 
animal models of  cell dysfunction enhances  cell insulin content and GSIS, 
and promotes  cell mass and glucose tolerance (34,35).  Therefore, loss of 
 8 
Pdx1 expression may also contribute to  cell dysfunction and glucose 
intolerance in human populations, and strategies to enhance Pdx1 expression 
may prove valuable as therapies for diabetes. 
 
1.2 ISLET  CELL DYSFUNCTION IN DIABETES MELLITUS 
 Despite its central importance in regulating energy metabolism, the  cell 
is subject to a number of stressors that can lead to its dysfunction or death in the 
setting of diabetes.  This is compounded by the fact that  cells have limited 
numbers and a low inherent replication rate (36).  The extent to which an 
individuals  cells are able to maintain their function may distinguish those who 
are at risk of developing diabetes from those who are not (37).  Indeed,  cell 
dysfunction and/or failure underlie all forms of diabetes.    
 Diabetes mellitus comprises a number of disorders resulting from absolute 
or relative insulin insufficiency, resulting in hyperglycemia (Fig. 1).  There are five 
main subtypes of diabetes: maturity onset diabetes of the young (MODY), type 1 
diabetes mellitus, latent autoimmune diabetes of adulthood, type 2 diabetes 
mellitus, and gestational diabetes mellitus.  Although the origins and progression 
of these diseases vary,  cell dysfunction or death is evident in each.  As such, 
research and therapies aimed at promoting  cell function and survival are critical 
to promoting health in an increasingly diabetic population. 
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A. Maturity Onset Diabetes of the Young 
 Monogenic forms of diabetes are rare diseases characterized by mild 
hyperglycemia, autosomal dominant inheritance, and onset prior to 30 years of 
age.  MODY results from mutations in genes critical to  cell development and 
function.  Currently, there are six recognized MODY genes, including HNF4A 
(MODY1), GCK (MODY2), HNF1A (MODY3), PDX1 (MODY4), HNF1B 
(MODY5), and NEUROD1 (MODY6) (38,39).  Most common among these forms 
of diabetes are MODY2 and MODY3 (39).  In addition to these, several other 
genes are associated with MODY-like phenotypes, including KLF11 (a regulator 
of Pdx1 transcription), PAX4, and preproinsulin (40). 
 Another form of monogenic diabetes associated with MODY is permanent 
neonatal diabetes mellitus.  Individuals affected by this disease display a more 
pronounced phenotype, experiencing severe hyperglycemia within the first weeks 
of life.  Permanent neonatal diabetes mellitus results from autosomal 
dominant/heterozygous mutations in KCNJ11 and ABCC8 genes, or from 
autosomal recessive/homozygous mutations in glucokinase, PDX1, and PTF1A 
(40). 
 
B. Type 1 Diabetes Mellitus 
 Type 1 diabetes (T1D), also commonly and incorrectly referred to as 
juvenile diabetes or insulin-dependent diabetes, comprises ~10% of all diabetes 
cases.  T1D results from autoimmune destruction of pancreatic  cells.  There is 
evidence to support an underlying  cell defect in the setting of T1D, which may 
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lead to  cell autoantigen presentation and subsequent activation of the 
autoimmune response (41).  Whereas the signals initially promoting  cell 
autoimmunity remain unclear, subsequent presentation and processing of  cell 
autoantigens, loss of immune tolerance, and generation of autoreactive T and B 
cells are hallmarks of T1D.  Macrophages, T cells, and dendritic cells infiltrate the 
islet (insulitis), secreting proinflammatory cytokines including interleukin 1 (IL-
1), tumor necrosis factor  (TNF-), and interferon  (IFN-), and allowing 
cytotoxic T cell mediated  cell destruction (42–44).  Proinflammatory cytokines 
activate signaling cascades that lead to  cell dysfunction and death (discussed 
in Chapter 1.3).  
 
C. Latent Autoimmune Diabetes of Adults 
 Latent autoimmune diabetes of adults, also incorrectly called type 1½ 
diabetes, is a disease characterized by adult onset of autoimmune mediated  
cell dysfunction and death.  It is characterized by its slowly progressive nature, 
residual insulin secretion, and common misdiagnosis as type 2 diabetes (T2D).  
The pathogenesis of this form of diabetes is similar to that of T1D in that insulitis 
leads to  cell dysfunction and death, however this process takes place as a 
substantially reduced rate compared with T1D (45). 
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D. Type 2 Diabetes Mellitus 
 Type 2 diabetes (T2D) is the most common form of diabetes, comprising 
up to 90% of all cases.  T2D is characterized by loss of insulin sensitivity in 
peripheral tissues, and is associated with obesity.  Notably, it is believed that only 
30% of obese, insulin resistant individuals eventually develop T2D, suggesting 
that other factors contribute to development of diabetes (46).  The majority of 
insulin resistant individual maintain euglycemia by increasing insulin production 
through a process known as compensatory  cell hyperplasia, which results in an 
increase in both  cell mass and function (47).  During this process, blood 
glucose concentrations remain normal, and blood insulin concentrations are 
elevated.  In individuals who eventually develop T2D, this compensatory increase 
in  cell mass and insulin production fails, leading to insulin insufficiency and 
frank hyperglycemia.  Interestingly, genome-wide association studies identifying 
candidate gene polymorphisms/mutations that confer risk for T2D uncovered 
genes related to  cell development and function (37,48).  Other factors 
contributing to  cell dysfunction in models of T2D include saturated free fatty 
acids (FFAs) and proinflammatory cytokines (discussed in Chapter 1.3). 
 
E. Gestational Diabetes Mellitus  
 Physiological changes related to pregnancy induce a state of insulin 
resistance similar to that observed in T2D (49,50).  In most cases, the  cell 
responds with compensatory  cell hyperplasia similar to that seen in T2D, 
resulting in increased insulin production, and maintenance of euglycemia.  
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However, in approximately 10% of pregnancies, the  cell is unable to effectively 
compensate, leading to insulin insufficiency, glucose intolerance, and gestational 
diabetes (51).  Those pregnancies complicated by gestational diabetes pose a 
risk for recurrence of gestational diabetes in future pregnancies, as well as future 
progression to T2D (52).  Notably, recent studies revealed a decline in  cell 
function in the first year postpartum in women diagnosed with gestational 
diabetes, suggestive of a role for  cell dysfunction in this form of diabetes (53). 
  
1.3 MEDIATORS OF  CELL DYSFUNCTION 
 Several factors contribute to the etiology of  cell dysfunction and death, 
including glucolipotoxicity (54), cytokines released from adipocytes, activated 
macrophages, and  cells themselves (55,56), and islet amyloid deposition 
(57,58), among others (see ref. (59) for a review) (Fig. 3).  Recently, many of 
these stressors have come to be viewed as mediators of islet inflammation.  As 
such, inflammation may represent a unified target for diabetes treatment.  In the 
setting of type 2 diabetes, inflammatory mediators including FFAs and 
proinflammatory cytokines emanate from adipose tissue itself (60). Insulin 
resistance, which is associated with obesity and T2D, is considered by many to 
be a result of chronic inflammation (61). Islet amyloid polypeptide (IAPP) 
deposition is associated with T2D and  cell dysfunction, and its detrimental 
effects are mediated through its activation of the inflammasome, which promotes 
maturation of inflammatory cytokines (see Chapter 1.3B) (62).  Islet inflammation 
is also an accepted component of autoimmune destruction of  cells in T1D (63).  
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Alone, each of these factors can impair  cell function, leading to inflammation 
and  cell loss.  However, in the setting of diabetes,  cells are likely subject to 
many such factors at a given time.   
 
A. Lipotoxicity 
 Lipotoxicity arises as a consequence of obesity and high fat diets, 
triggering impairments in insulin release and eventual  cell apoptosis (64).  
Circulating saturated FFAs have long been known to affect  cell signaling and 
function (65).  One such fatty acid, palmitate, causes ER stress, oxidative stress, 
and c-Jun N-terminal kinase (JNK) activation in vivo, all of these promoting 
inflammation.  Palmitate also enhances inflammation via induction of IL-1, TNF-
, IL-6, and IL-8 production, as well as activation of NF-B signaling in islets 
(66,67).  Elevated glucose and FFA concentrations lead to oxidative stress in 
islet  cells, which are particularly vulnerable to due to low antioxidant defense 
(63,68).  Oxidative stress results from an imbalance between the presence of 
reactive oxygen species (ROS) and the cell’s ability to clear the reactive species 
and repair the resulting damage (69).  Oxidative stress mediates inflammatory 
responses in the  cell through activation of JNK, NF-B, and p38 mitogen 
activated protein kinase (MAPK) (70). 
 Recent studies suggest that FFAs are required for maintenance of normal 
glucose responsiveness (65,71), raising the possibility that FFAs contribute to 
elevated insulin secretion in the initial stages of T2D (72).  Alternatively, chronic 
exposure of  cells to FFAs leads to impairments in GSIS, reductions in insulin 
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gene expression, and  cell apoptosis (73–75).  Thus, although FFA induced 
compensatory  cell function is a beneficial adaptation in the short term, 
evidence suggests this adaptation can be harmful in the long run.   
 
B. Islet Amyloid Polypeptide 
 IAPP is synthesized in the  cell and is co-secreted with insulin; however, 
its physiological role remains unclear (76,77).  Similar to amyloid deposition in 
Alzheimer’s disease, IAPP can oligomerize into fibrils, and form islet amyloid 
deposits, which contribute to islet inflammation (78).  Factors associated with 
amyloid formation include IAPP amino acid sequence, as well as chronically 
elevated glucose and FFA levels (79).  Mouse islets over-expressing 
amyloidogenic human IAPP exhibit oxidative stress, and this contributes to 
amyloid-induced  cell apoptosis (58).  This amyloid-induced apoptosis is 
mediated by JNK activation (80).  Further, amyloid deposition triggers the NLRP3 
inflammasome, a complex which generates mature IL-1 (62).  Thus, islet 
amyloid deposition represents another factor promoting inflammation, oxidative 
stress, and  cell death in T2D. 
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C.  Cell Dedifferentiation 
 Recently, studies have proposed a role for  cell dedifferentiation in the 
pathogenesis of diabetes (81,82).  Whereas it is appreciated that diabetes is 
linked to  cell failure, it is unclear whether this failure is attributable primarily to  
dysfunction or reduced  cell mass.  Studies of mouse models of diabetes have 
revealed that loss of  cell mass contributes to  cell failure, but interestingly, the 
driver of this process may not be  cell death, but instead  cell dedifferentiation 
into into t or some other cell type (81,83).  In vitro models also demonstrate that 
 cells undergo dedifferentiation into an insulin-, Pdx1-, and GLUT2-negative 
form (82).  This evidence demonstrates that  cell dedifferentiation is another 
mechanism of  cell loss in the setting of diabetes (81).  Thus, preservation of  
cell identity is required for maintenance of  cell mass and function in the setting 
of diabetes. 
 
D. Proinflammatory Cytokines  
 Islet  cells are subject to the effects of proinflammatory cytokines in the 
setting of both T1D and T2D.  In states of obesity as seen in T2D, adipose tissue 
accumulates and undergoes phenotypic changes, becoming a primary source of 
circulating proinflammatory cytokines that contribute to systemic inflammation 
(60,84).  In the setting of T1D, islet-infiltrating immune cells and the  cell itself 
produce cytokines, contributing to the pathophysiology of this form of diabetes 
(55,56).    
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 Proinflammatory cytokines (e.g. IL-1, TNF-, and IFN-, referred to 
hereafter as cytokines) are known to exert a number of detrimental effects on  
cells. Cytokines trigger NF-B, JNK, p38 MAPK, and STAT1 dependent 
signaling, and the intrinsic mitochondrial death pathway (55,66,85,86).  Signaling 
through NF-B dependent pathways contributes to transcription of Nos2 mRNA, 
iNOS protein expression, and nitric oxide (NO) production (87).  The resultant 
oxidative stress impairs glucose oxidation and ATP production, consistent with 
mitochondrial dysfunction and production of ROS (88).  NO also mediates the 
cytokine induced unfolded protein response (UPR) in  cells (89), possibly via 
decreased SERCA2 expression and ER Ca2+ dysregulation (90).  Further, NO is 
associated with  cell necrosis and apoptosis (91).  Cytokines enhance signaling 
via MAPK cascades, including through JNK and p38 in the  cell (92). Moreover, 
activation of signal transducer and activator of transcription 1 (STAT1) via TNF- 
and IFN- leads to Bim activation and  cell apoptosis (93).  The intrinsic 
mitochondrial death pathway is believed to play a central role in mediating 
cytokine induced  cell death, with calcineurin mediated Bad dephosphorylation 
and Bax activity contributing significantly (85).  Bim, Bad, and Bax are all pro-
apoptotic molecules of the apoptosis regulating Bcl-2 family of proteins. Through 
these pathways and others, proinflammatory cytokines promote  cell 
dysfunction and eventual apoptosis. 
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Figure 3:  cell stress leads to reduced  cell mass and function, and 
diabetes.  Factors associated with the diabetic environment including free fatty 
acids, proinflammatory cytokines, islet amyloid, and genetic predisposition trigger 
lipotoxic, oxidative, and ER stress in the  cell.  These stressors contribute to  
cell dysfunction, dedifferentiation, loss of proliferation, and apoptosis.  In turn, 
this leads to reduced  cell mass and function, and diabetes. 
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1.4  CELL ENDOPLASMIC RETICULUM STRESS 
 As a professional secretory cell type, the  cell is particularly dependent 
upon the integrity of its ER to process, fold, and export insulin.  These functions 
of the ER are tightly regulated and in a state of precarious homeostasis.  As 
such, minor perturbations in the oxidative state of the cell, peripheral tissue 
insulin demand, and cellular energetics can all impose stress on the ER 
(discussed in Chapter 1.4B).  
 
A. The Endoplasmic Reticulum 
 The ER is a eukaryotic organelle consisting of an interconnected 
membrane network containing luminal and cytosolic surfaces, which are 
contiguous with the outer membrane of the nuclear envelope.  Signal peptides 
encoded by the first 5-30 amino acids of certain proteins (most notably insulin) 
associate with a signal recognition particle (SRP), and the ribosome and signal 
particle complex translocate to the ER membrane (94).  Ribosomes associated 
with the cytosolic surface of the ER membrane participate in the synthesis of 
secreted and membrane bound proteins, which are translocated into the ER 
lumen through a translocon (95).  Chaperone proteins in the ER lumen, including 
protein disulfide isomerase (PDI), BiP, calnexin, and calreticulin then aid in the 
proper folding of these proteins so that they may be exported.  Importantly, a 
number of these chaperones Ca2+ dependent, highlighting the importance of Ca2+ 
regulation in the ER lumen (94).  The ER lumen is an oxidative environment, 
allowing formation of disulfide bonds and folding of secretory and membrane 
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bound proteins (96).  In the  cell, insulin synthesis places a high demand on the 
protein folding capabilities of the ER.  In certain scenarios, the demand placed on 
the ER for protein processing can exceed the ER capacity, leading to the 
accumulation of unfolded proteins and activation of the unfolded protein 
response (UPR). 
 Due to their heavy engagement in synthesis and secretion of insulin,  
cells are sensitive to ER stress and subsequent UPR.  Prolonged exposure to ER 
stress may lead to eventual  cell failure and death.  Additionally, established  
cell stressors such as free fatty acids and proinflammatory cytokines have been 
demonstrated to cause ER stress (see Chapter 1.3).  Models of ER Ca2+ 
dysregulation, such as inhibition of the sarco/endoplasmic reticulum Ca2+ 
ATPase (SERCA) with thapsigargin, and defective protein processing are also 
consistent with ER stress (97,98). 
  
B. ER Stress in Diabetes 
 The association between obesity, insulin resistance, and T2D is well 
established, and stablisER stress is one mechanism involved in these processes.  
In the setting of insulin resistance and T2D,  cells are exposed to high glucose 
and FFAs, and are compelled to maintain elevated insulin secretion, representing 
a scenario wherein  cells are subjected to ER stress (99).  Importantly, in mouse 
models of type 2 diabetes, treatment with chemical chaperones reduces ER 
stress and restores glucose homeostasis (100).  It has also been shown that 
saturated FFAs such as palmitate trigger ER stress in  cells, contributing to 
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cellular apoptosis in models of T2D (101,102).  Palmitate is thought to initially 
enhance protein synthesis via mTOR activation in the  cell, whereas in the 
longer run, this activation of protein synthesis contributes to  cell ER stress 
(103).  
 Interestingly, recent evidence has implicated ER stress in T1D as well.  
Type 1 diabetes (T1D) is characterized by loss of immune tolerance to insulin-
producing  cells, first leading to impaired insulin production and later to  cell 
destruction and frank hyperglycemia (104,105).  Whereas many studies have 
focused on the immune system as the primary trigger of T1D, emerging data 
have pointed to a potentially equally important role of the 
http://zotero.org/users/1897719/it(43,104).  Indeed, proinflammatory cytokines 
secreted by infiltrating immune cells are known to reduce sarco/endoplasmic 
reticulum Ca2+-ATPase 2 (SERCA2) protein expression, resulting in improper  
cell Ca2+ homeostasis, and ER stress (90).  Recent studies in pre-diabetic non-
obese diabetic (NOD) mice (a model of T1D) have suggested that the 
accumulation of unfolded proteins in the endoplasmic reticulum leads to ER 
stress prior to onset of frank type 1 diabetes (41,106).  It has also been 
hypothesized that in  cells, ER stress is a major driver of neoantigen exposure, 
and thereby a trigger for autoimmunity.  In support of this hypothesis, NOD mice 
treated with chemical protein folding chaperones have more robust  cell function 
and a significantly reduced incidence of diabetes (107).  Further, expression of 
ER stress markers has now been observed in islets of individuals with T1D (108). 
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1.5 THE UNFOLDED PROTEIN RESPONSE 
 ER stress leads to activation of the UPR, which initially attempts to 
remediate stress.  Severe or prolonged episodes of ER stress may lead to UPR 
directed death of  cells, contributing to the development of diabetes (96).  
During periods of UPR activation, three ER membrane-resident signaling 
proteins are activated: inositol-requiring enzyme 1 (IRE1), activating transcription 
factor 6 (ATF6), and protein kinase R (PRKR)-like endoplasmic reticulum kinase 
(PERK), which collectively function to remediate ER stress by promoting protein 
folding and suppressing new protein production (Fig. 4) (109).  The UPR is 
activated in response to accumulation of unfolded or misfolded proteins in the 
lumen of the ER.  During ER homeostasis, the protein chaperone BiP binds the 
ER intraluminal portion of PERK, IRE1, and ATF6, maintaining them in a non-
active confirmation.  During periods of ER stress, unfolded and misfolded 
proteins compete for more of the available BiP, resulting in its dissociation from 
PERK, IRE1, and ATF6 (110).  This leads to activation of the UPR, which signals 
initially for adaptation and stress remediation, and later for apoptosis (111).  The 
UPR may also contribute to processes including eukaryotic starvation responses 
and differentiation programs via nutrient sensing and promotion of ER membrane 
biosynthesis (112). 
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A. Activating Transcription Factor 6 
 Activating transcription factor 6 (ATF6) is a stress inducible ER 
membrane-resident transcription factor that regulates transcription of UPR target 
genes, such as the protein chaperone BiP (113).  ATF6 differs from most 
transcription factors in that it is synthesized as a transmembrane protein inserted 
in the ER membrane.  ER stress induces trafficking of ATF6 to the Golgi 
apparatus, and subsequent proteolysis from the membrane.  ATF6 is then free to 
translocate to the nucleus and facilitate transcription of its target genes (114).  
ATF6 polymorphisms are associated with impaired glucose tolerance and T2D in 
human populations, illustrating the relevance of this molecule to human disease 
(115,116). 
 
B. Inositol-Requiring Enzyme 1 
 The ER transmembrane protein inositol-requiring enzyme 1 (IRE1) senses 
ER homeostasis via its interaction with BiP in the ER lumen, and promotes the 
UPR via its cytoplasmic kinase domain (117).  After BiP dissociates from the 
IRE1 intraluminal domain, IRE1 becomes activated by autophosphoryltion, 
conformational change, and oligomerization (117).  IRE1 activation initiates 
signaling through diverse UPR mechanisms.  Notably, IRE1 mediates splicing of 
a 26 amino acid intron from the transcription factor X-box binding protein 1 
(Xbp1), leading to expression of Xbp1.  In turn, Xbp1 directs transcription of ER 
biogenesis and protein chaperones genes (118).  During the adaptive UPR, IRE1 
directs mRNA degradation of multiple substrates through the process of 
 23 
regulated IRE1-dependent decay (RIDD) in an effort to reduce the translational 
load placed on the ER (119).  If this adaptation is unsuccessful, IRE1 contributes 
to pro-apoptotic UPR signaling via RIDD of anti-apoptotic pre-miRNAs (120).  
Furthermore, IRE1’s kinase domain phosphorylates JNK, contributing to pro-
apoptotic signaling (118).  Underscoring the importance of IRE1 in regulating 
protein synthesis, IRE1 mutation is embryonic lethal at day E9.5-10.5 (121). 
 
C. PRKR-Like Endoplasmic Reticulum Kinase  
 Protein kinase R (PRKR)-like endoplasmic reticulum kinase (PERK), 
another ER transmembrane protein, comprises the third arm of the UPR.  Similar 
to IRE1, PERK is activated when BiP dissociates from its ER luminal domain, 
leading to oligomerization and autophosphorylation (117).  PERK has been 
implicated in regulation of endoplasmic reticulum associated degradation 
(ERAD), a mechanism that targets misfolded proteins in the ER lumen for 
ubiquitination and subsequent proteosomal degradation (122).  Additionally, 
PERK plays a critical role in protein trafficking and secretory pathway quality 
control (123).   
 A primary function of PERK is to phosphorylate the translation initiation 
factor eIF2.  During the UPR, the phosphorylation of eukaryotic translation 
initiation factor 2 (eIF2) by PERK causes suppression of general protein 
synthesis (124).  This is an adaptive mechanism to decrease the translational 
load placed on the ER (125).  Whereas general protein synthesis is attenuated 
under conditions of eIF2 phosphorylation, translation of certain mRNAs such as 
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Atf4 and Chop is enhanced (126,127).  Distinct mechanisms of translational 
initiation allow this specific regulation of protein synthesis to occur during ER 
stress (discussed in Chapter 1.6A).  Despite its initial adaptive function, excess 
phospho-eIF2s is poorly tolerated in  cells, exacerbating apoptosis (128).  
Alternatively, mutation of PERK in mice and in human populations leads to 
infancy onset of diabetes (129,130).  Whereas many studies have elucidated the 
transcriptional responses of the UPR (downstream of ATF6 and IRE1), fewer 
studies have investigated the translational responses of the UPR (downstream of 
PERK) in the  cell.  
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Figure 4: The unfolded protein response.  The unfolded protein response is 
activated in response to accumulation of unfolded proteins in the lumen of the 
ER.  During periods of ER stress, the folding chaperone BiP is recruited away 
from PERK, ATF6, and IRE1, resulting in activation of these signaling 
intermediates.  ATF4, CHOP, ATF6, and XBP1 proteins are generated, driving 
transcriptional responses intended to expand ER protein folding capacity and to 
remediate ER stress.  Translational regulation following eIF2 phosphorylation is 
also active during the UPR.  General protein synthesis is inhibited by phospho-
eIF2, while translation of a specific subset of transcripts is enhanced or 
maintained (Atf4, Chop). 
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D. The Role of Pdx1 in  Cell ER Homeostasis  
 Recently, studies have shed light onto the importance of Pdx1 in 
maintaining by phospho-eIF2 genera(32).  Whereas mutation of the Pdx1 gene in 
both mice and humans results in pancreatic agenesis, Pdx1 heterozygosity leads 
to MODY4 (see Chapter 1.2A) (13).  Pdx1+/- mice fed a high fat diet show 
heightened susceptibility to ER stress owing to failure in the UPR (32).  Pdx1 
plays a key role in the UPR by directly promoting transcription of Atf4, Wfs1, and 
Ero1b, among others (32).  Thus, in both type 1 and type 2 diabetes, Pdx1 levels 
may serve as a barometer of  cell ER stress susceptibility.  Interestingly, Pdx1 
mRNA and protein levels are reduced in NOD mice, which correlated with 
deficiencies in islet glucose responsiveness in vitro and elevated levels of Bip 
mRNA, spliced Xbp1 mRNA, and serum proinsulin compared to control mice 
(41).  These findings may be related to an inherent genetic feature of the NOD 
tcell, and may offer insight into the susceptibility of mice on the NOD 
background to , cell dysfunction.  Therefore, Pdx1 may represent a factor unique 
to the  cell that is required for maintenance of ER homeostasis. 
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1.6 MESSENGER RNA TRANSLATION IN THE ISLET  CELL 
 Studies into  cell translational regulation are critical to understanding  
cell dysfunction and death in the setting of diabetes.  In addition to translational 
regulation downstream of ER stress and eIF2 phosphorylation, many 
mechanisms involving availability, activity, and assembly of translation factors 
have been linked to diabetes.  Among these are translation initiation factors such 
as eIF4G and eIF4E, and translation elongation factors such as eIF5A (131–
133).  Moreover, studies of global mammalian gene expression have revealed a 
lack of correlation between transcript and protein abundance in cells (134,135).  
Although mRNA and protein stability may also contribute to this phenomenon, 
the data suggest that protein expression is regulated principally at the level of 
translation.  However, relatively little research has focused on translational 
responses of the islet  cell to diabetes-related stressors.  The studies conducted 
here address this gap in knowledge.     
 Translation is the process by which ribosomes create proteins from an 
mRNA template.  Messenger RNAs produced via gene transcription are 
translated by ribosomes using aminoacyl tRNAs to produce specific amino acid 
polypeptides, which then fold to form an active protein (136,137).  Eukaryotic 
translation proceeds through the regulated processes of translation initiation, 
elongation, and termination (Fig. 5).  Each of these processes utilizes specific 
translation factors that are necessary for accurate and efficient mRNA translation 
(136,137).  Translation is regulated primarily at the level of initiation.  However, 
 28 
recent evidence suggests there is significant regulation at the level of translation 
elongation as well (133,138,139).  
 
 
 
 
 
 
 
 
 
Figure 5: Processes of eukaryotic translation.  Eukaryotic translation takes 
places through three coordinated processes, initiation, elongation, and 
termination.  Translation initiation requires mRNA, ribosome subunits, eIFs, and 
Met-tRNA; elongation requires ribosome subunits, mRNA, eEFs, and aminoacyl 
tRNAs; termination requires ribosome subunits, mRNA, and eRFs.  Together 
these processes initiate translation at a start codon, polymerize the growing 
polypeptide, release the protein for processing and activity, and recycle ribosome 
subunits and translation factors for use in subsequent cycles of translation. 
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A. Translation Initiation  
 Translation initiation is believed to be the most critical process in 
regulating translation, and it is the most well studied event in translation (137).  
Most cellular mRNAs are translated via a 5’-7-methylguanylate cap dependent 
mechanism (Fig. 6).  This mechanism allows assembly of eukaryotic translation 
initiation factors (eIFs) and the ribosomal preinitiation complex at the 5’ cap, 
facilitating scanning by ribosomes to the translation initiation start site (137).  The 
eIF4F cap-binding complex is composed of eIF4E, which binds the mRNA 5’ cap, 
eIF4G, a scaffolding protein linking the mRNA cap to the ribosome preinitiation 
complex, and eIF4A, an ATP-dependent RNA helicase.  The 43S ribosome 
preinitiation complex is comprised of a 40S ribosomal subunit, an eIF2-GTP-Met-
tRNA ternary complex, eIF3, eIF1, and eIF1A (140).  Association of this complex 
with the mRNA 5’ cap allows 5’ to 3’ scanning of the 43S ribosome to reach the 
initiation codon.  Once the 43S complex recognizes the initiation codon and the 
48S complex is formed, eIF2 bound GTP is hydrolyzed by eIF5 and eIF5B.  This 
leads to displacement of eIFs and joining of the large, 60S ribosome subunit to 
form a fully translation competent ribosome (137).   
 Translation initiation can be regulated via eIF2 phosphorylation, 
availability and assembly of initiation factors required for cap-dependent 
translation, by mRNA binding proteins, and importantly, by varied mechanisms 
involving the sequence of the mRNA 5’ untranslated region (UTR) (137,140–
142).  One of the most fully understood models of  cell stress-induced 
translational regulation involves unfolded proteins in the ER lumen activating 
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PERK, which subsequently phosphorylates eIF2 (Fig. 4).  The guanine 
nucleotide exchange factor (GEF) eIF2B is maintained in an inactive 
conformation during periods of high eIF2 phosphorylation, impairing GDP to 
GTP exchange on eIF2, thus inhibiting global eIF2 dependent translation 
initiation (137).  This adaptive response decreases the translational load placed 
on the ER.  Essential for eventual stress adaptation, GADD34 is a stress 
inducible protein phosphatase that directs the dephosphorylation of eIF2 (143).   
 While translation of most proteins is down regulated during ER stress and 
eIF2 phosphorylation, certain mRNAs necessary to mount an appropriate 
response to stress are translationally up regulated under these conditions.  Key 
to the mechanisms allowing such translational enhancement are inhibitory 
upstream open reading frames (uORFs) in the 5’ UTRs of these mRNAs 
(127,142,144).  Many mRNAs relevant to  cell stress response are believed to 
utilize inhibitory upstream open reading frames, including Atf4, Chop, Atf5, and 
Gadd34 (144).  During ER homeostasis, relatively little phosphorylated eIF2 is 
present, and initiation at start codons is very efficient.  Under such conditions, 
inhibitory upstream open reading frames in the mRNA 5’ UTR capture scanning 
preinitiation complexes, initiating protein synthesis of short peptides, and 
preventing ribosome access to the downstream protein coding ORF.  Under 
conditions of ER stress, when phosphorylated eIF2 levels increase, initiation at 
start codons becomes less efficient.  Therefore, scanning ribosomes are less 
likely to initiate translation at inhibitory uORFs, increasing the frequency of 
translation initiation at the main, protein coding, ORF (145).  Through this 
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mechanism, mRNAs necessary for stress adaptation activate their translation 
under appropriate conditions.  Although such mechanisms are generally 
accepted for all cell types, these specific mechanisms of translational activation 
have not been fully examined in the  cell.  In the following studies, we assess 
the function of these mechanisms in  cells using techniques to investigate 
translational regulation. 
 Internal ribosome entry sites (IRESs) represent another mechanism 
allowing maintenance of translation initiation under conditions of stress.  IRESs 
are RNA elements found in the 5’ UTR that permit end independent recruitment 
of ribosomes to maintain or enhance translation initiation under periods of stress 
(141).  Importantly, cellular mRNAs containing IRESs may also be translated via 
a cap-dependent ribosome scanning mechanism, raising questions about when 
one or the other mechanism predominates (137).  Although IRESs are 
associated with mRNA secondary structure, there is little conservation of 
structure among known IRESs, and precise mechanisms of action are not well 
defined.  However, eIF4G and eIF4A are believed to be necessary for activity of 
many cellular IRESs (137).  Elevated eIF4G expression in certain breast cancers 
strongly drives IRES mediated translation of p120 catenin and of vascular 
endothelial growth factor (VEGF) mRNA (146).  IRES trans-acting factors 
(ITAFs), RNA binding proteins postulated to stabilize optimal IRES conformation, 
also participate in regulation of IRES mediated translation initiation (147) .  
Although transcripts relevant to  cell stress response, including Bip and Xiap, 
are known to utilize IRES elements, these types of translational regulation have 
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not been investigated in the  cell (148,149).  The following studies represent 
some of the first to investigate the relevance of IRES mediated translation to  
cell physiology. 
 
 
 
 
 
Figure 6: Translation initiation.  In cap-dependent translation initiation, the 
small ribosomal subunit (40S) is recruited to the 5’ cap structure through its 
interaction with the eIF4F cap binding complex.  The ribosome then “scans” the 
5’ UTR until is encounters a start codon (AUG).  Codon-anticodon interaction and 
initiation factors contribute to start codon selection.  Several factors are left out of 
the schematic for clarity.  Internal ribosome entry site (IRES)-mediated 
translation initiation allows assembly of the ribosome complex independently of 
the 5’ cap structure.  After recognition of the start codon, binding of the large 
ribosomal subunit (60S) forms a functional ribosome.  This process involves 
hydrolysis of eIF2 bound GTP, and release of initiation factors. 
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B. Translation Elongation 
 Following translation initiation, several mechanisms are involved in 
elongation of the forming polypeptide.  Central to this process are eukaryotic 
translation elongation factors (eEFs), including eEF1A and eEF2 (150).  When an 
80S ribosome is positioned on an mRNA with the anticodon of Met-tRNA base 
paired with the start codon in the ribosome P-site, initiation is complete and 
elongation may proceed.  At this stage, the second codon of the ORF waits for its 
cognate aminoacyl tRNA in the ribosome A-site.  Elongation factor eEF1A then 
binds aminoacyl-tRNA, directing the tRNA to the ribosome A-site in a GTP 
dependent manner.  Codon recognition by this tRNA then prompts eEF1A 
mediated GTP hydrolysis, releasing the elongation factor and completing tRNA 
association with the A-site (150).  Following accommodation of the tRNA in the 
A-site, peptide bonds are rapidly formed with the peptidyl-tRNA of the P-site.  
Critical to this mechanism is the ribosome peptidyl transferase center (PTC), 
which consists predominantly of rRNA elements of the 60S subunit, and 
functions to optimally position substrates for catalysis (151).  After peptide bond 
formation, translocation of tRNAs to the E-site and P-site is catalyzed by 
elongation factor eEF2.   Hydrolysis of GTP by eEF2 at the ribosome leads to 
conformational changes to eEF2 and the ribosome, which are thought to allow 
uni-directional translocation of tRNAs through the ribosome (150).  Now, the 
peptidyl-tRNA occupies the P-site, and the A-site is once again vacant, awaiting 
the next aminoacyl-tRNA-eEF1A complex.      
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 The process of translation elongation is regulated by mechanisms 
involving a variety of elongation factors.  For example, following hydrolysis of 
eEF1A associated GTP, the GDP bound eEF1A complex must undergo 
nucleotide exchange to reacquire GTP and activity.  Thus, eEF1B, which 
catalyzes guanine nucleotide exchange of eEF1A, plays a key role in regulating 
eukaryotic translation elongation (150).  Additionally, the translational activity of 
eEF2 is regulated by post-translational modification.  Phosphorylation of eEF2 by 
eEF2 kinase (eEF2K), results in impaired eEF2-ribosome interaction, and 
blockade of translational elongation (152,153).   
 Interestingly, eEF2 is subject to a unique post-translational modification 
impacting translation.  A conserved His residue of eEF2 undergoes a unique 
post-translational modification to form the amino acid diphthamide (154).  
Mutation of this eEF2 residue results in impaired cell growth, and mice lacking 
enzymes required for diphthamide formation are subject to embryo lethality or 
severe developmental defects.  These data indicate a positive role for 
diphthamide in translation (155,156).  The ability of external stimuli to regulate 
function of translation elongation factors via these processes is an incompletely 
understood area of translation regulation.  
 
C. Elongation Factors eIF5A and DHS 
 Eukaryotic translation initiation factor 5A (eIF5A), is a small (17 kDa) 
protein that is highly conserved throughout evolution and is expressed in a broad 
range of cell types in mammals (157).  Originally termed a translation initiation 
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factor due to its ability to stimulate methionyl-puromycin synthesis, eIF5A is now 
thought to function primarily as a translational elongation factor (158).  Depletion 
of eIF5A in yeast and mammalian cells results in the accumulation of 
polyribosomes and in prolonged ribosome transit times (158,159).  Importantly, 
loss of eIF5A in yeast results in a ~30% decrease in protein synthesis rates 
(160).  However, in unstressed mammalian cells, it has been reported that 
depletion of eIF5A results in the impaired translational elongation of only about 
5% of mRNAs (159).  Both of these findings argue against a role for eIF5A as a 
general translation factor, and instead point to a more restricted role in the 
translation of a subset of mRNAs (161,162).  Studies into the mechanisms of 
eIF5A have proposed a model whereby active eIF5A serves to catalyze peptide 
bond formation between unfavorable amino acid substrates such as polyproline 
motifs, reducing ribosome stalling on mRNA (138,139).  Intriguingly, other data 
suggests that ribosome stalling on certain eukaryotic transcripts contributes to 
IRES mediated translation initiation (163).  Thus, there may be a link between 
IRES activity and hypusinated eIF5A in translational regulation.  
 Similar to the diphthamide modification of eEF2, eIF5A also undergoes an 
unusual posttranslational modification, forming hypusine.  Hypusine is required 
for virtually all of the functions of eIF5A studied to date, including RNA binding, 
mRNA shuttling, and translational elongation (164).  Hypusine synthesis is 
catalyzed by the sequential actions of deoxyhypusine synthase (DHS) and 
deoxyhypusine hydroxylase (DOHH), which together transfer the polyamine 
moiety of spermidine to the neine moiety of spermidineentia (Fig. 7) (165).   
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 DHS catalyzes the rate-limiting step in the hypusine biosynthetic pathway, 
and as such, represents a target for inhibiting the overall rate of hypusine 
formation.  Inhibition of hypusination may attenuate translation of specific mRNAs 
involved in  cell dysfunction.  Several inhibitors of DHS have been described, all 
classified as polyamines with structural homology to spermidine.  Perhaps the 
best studied and most potent inhibitor is N1-guanyl-1,7-diaminoheptane (GC7), 
which exhibits a Ki of 10 nM in vitro (about 450-fold lower than the Km for 
spermidine) (166).  Xray crystallographic analysis of DHS at near-optimal pH and 
ionic conditions shows that GC7 is specifically bound within a deep acidic active 
site tunnel (167).  Inhibition of DHS using GC7 and similar polyamines was 
shown to have a repressive effect on proliferation in both yeast and mammalian 
cell cultures as soon as 24h, with a particularly striking inhibition at the G1/S 
transition of the cell cycle (168–170).  Given its role as a translational regulator of 
stress responsive mRNAs, it is interesting to speculate about what types of 
signals may activate or repress hypusine mediated eIF5A activity, what the 
mRNA targets of eIF5A are, and how pharmacological and genetic models of 
DHS insufficiency affect  cell function and survival.  In the studies outlined 
herein, I investigated mechanisms of hypusine-eIF5A mediated translational 
elongation in the islet  cell. 
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Figure 7: Hypusination of eIF5A.  Deoxyhypusine synthase (DHS) and 
deoxyhypusine hydroxylase (DOHH) act sequentially to form a hypusine residue 
at lysine 50 of eIF5A.  The small molecule GC7, a spermidine analog, inhibits 
DHS function, suppressing eIF5A hypusination. 
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D. Translation Termination  
 Termination is perhaps the least well studied of the three stages of 
translation.  This process occurs when the ribosome reaches a stop codon at the 
end of a protein coding sequence, and utilizes eukaryotic translation release 
factors (eRFs) (150).  Eukaryotic termination is directed cooperatively by eRF1, 
eRF3, and ABCE1/Rli1.  After recognition of the stop codon, the eRF1-eRF3-
GTP complex binds the ribosome A-site, leading to eRF3 mediated GTP 
hydrolysis and subsequent eRF3 release (171,172).  ABCE1/Rli1 then facilitates 
accommodation of eRF1 into optimal configuration, leading to peptide release 
and subunit dissociation (150).  Release factor eRF1 is essential for ABCE1 
activity, which promotes dissociation and recycling of post-termination complexes 
into free ribosomal subunits (173).  Although relatively little is known about 
regulation of translation termination, processes of subunit and translation factor 
recycling play significant roles in maintaining efficient translation. 
 
1.7 SUMMARY  
 Islet  cell research has now provided convincing evidence that loss of  
cell function is the key determinant in development of both type 1 and type 2 
diabetes (42,59).  As such, research focusing on maintenance of  cell health 
and function is well positioned to provide insights for development of new 
therapeutic strategies.  While  cell stress responses are generally well 
understood, little is currently known regarding  cell translational regulation, 
which is a likely consequence of inflammation, ER stress, and the UPR.  My 
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research has focused on defining the translational regulatory mechanisms that 
are operable in the islet  cell, and shedding new light on how these may be 
exploited for the treatment of diabetes.   
 Studies into stress induced translational changes will likely provide new 
insight for improved  cell function and survival.  Mechanisms anticipated to be 
relevant to  cell physiology include regulation of global translation initiation via 
phosphorylated eIF2 and 5’-7-methylguanylate cap components.  Also, 
transcript specific regulation of translational initiation (Atf4, Chop) and elongation 
are likely contributors to  cell stress response (see Chapter 1.7).  Careful study 
of these proposed mechanisms of translational regulation will establish their 
relevance to  cell physiology and add to the current understanding of  cell 
stress response. 
 In addition to validating targets of translational regulation in the  cell, the 
study of translational regulation of  cell specific transcripts will provide critical 
insight into how  cells maintain homeostasis under conditions of stress.  Recent 
data indicate Pdx1 is required for maintenance of ER homeostasis under 
conditions of  cell stress.  Indeed, Pdx1 is a direct transcriptional regulator of 
Atf4, Ero1lb, and Wfs1, and is linked to  cell Ca2+ homeostasis (32).  Since 
Pdx1 is a key contributor to the UPR, I suggest that maintenance of Pdx1 mRNA 
translation in the setting of ER stress is important for the adaptive stress 
response in  cells.   
 A primary goal of these studies was to determine the translational 
changes associated with  cell stress, including proinflammatory cytokines.  I 
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hypothesize that translational regulation is a key component of the pancreatic  
cell stress response.  Further, I hypothesize that Pdx1 mRNA maintains 
translation during ER stress, and that DHS and eIF5A are required for 
translational elongation of  cell transcripts involved in stress response.  To test 
these hypotheses, and to better understand  cell translational responses in 
general, I established cell culture systems in vitro that recapitulate the 
translational changes seen during ER stress.  I then investigated transcriptional, 
translational, and post-translational mechanisms related to translational 
regulation in the islet  cell.   
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CHAPTER 2 
Experimental Procedures  
 
2.1 MATERIALS 
A. Animals, Islets, and Cell Lines 
 Mice (C57BL/6) were bred and maintained at the Indiana University 
Laboratory Animal Resource Center under pathogen free conditions according to 
protocols approved by the Institutional Animal Care and Use Committee.  The 
mouse insulinoma cell line MIN6 was maintained in high glucose DMEM with 
15% FBS, 1% Pen/Strep, and supplemented with HEPES and sodium pyruvate.  
The rat insulinoma cell line INS1 (832/13) was maintained in RPMI with 10% 
FBS, 1%Pen/Strep, and supplemented with HEPES.  MEFs were maintained in 
DMEM supplemented with 10% FBS and 1% Pen/Strep following isolation.  
Briefly, one male and two virgin female mice were housed in each cage, and 
females were checked for copulatory plugs each morning until observation.  
Then, plugged females were removed to a separate cage.  Embryos were 
harvested at day E8.5 or E13.5 from euthanized pregnant females, washed with 
PBS, minced in 1X trypsin, and cells were allowed to grow onto tissue culture 
plastic at 37oC and 5% CO2.  Mouse islets were isolated from collagenase-
perfused pancreata as previously described (174).  Islets were picked by hand 
and counted, and then allowed to recover overnight in 11mM glucose RPMI 
before experimentation.  Human islets were obtained through the Integrated Islet 
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Distribution Program.  Upon arrival, human islets were placed in RPMI and 
allowed to recover overnight before experimentation. 
 
B. Antibodies 
 Primary antibodies previously described include anti-slet Distribution 
Program.  Upon arrival,anti-eIF5A, anti-eIF2A, anti-phospho-eIF2s, anti-p38, and 
anti-phospho-p38 (88,103,162,175).  Other primary antibodies used in these 
studies include anti-iNOS (06-573, Millipore or SC-8095, Santa Cruz 
Biotechnology), anti-Pdx1 (07-696, Millipore), and anti-CPE (11044, Abcam).  
Fluorophore labeled secondary antibodies IRDye 800 and IRDye 700 were 
purchased from Li-Cor Biosciences (Lincoln, NE). 
 
C. Vectors 
 The C49 dicistronic vector construct including the hSP-A 5’ UTR insert 
(C49 +, a gift from Patricia Silveyra and Joanna Floros) (176) was digested with 
EcoRI (New England Biolabs), separated on a 2% agarose gel, and the 
backbone and insert were gel purified (Qiagen).  PCR amplification of the hsPdx, 
mmPdx1, mmPdx1 truncation mutant, and CPE 5’ UTRs was carried out using 
the following primers.  For hsPdxUTR, 5’- AAAGCGAGCAGGGTGGCG-3’ 
(forward) and 5’- GGCTGCGGCCCGGGATT-3’ (reverse) were used. For 
mmPdxUTR, 5’- AAAATTGAAACAAGTGCAGGTG-3’ (forward) and 5’- 
GGTGGCAGCCGGCACTTG-3’ (reverse) were used.  For mmPdx1UTR 
truncation mutant, 5’- GTCAAAGCGATCTGGGGTG-3’ (forward) and 5’- 
 43 
GGTGGCAGCCGGCACTTG-3’ (reverse) were used.  For CPE-UTR, 5’-
GTGAGGCGAGAGGAGGCTGGTGCTG-3’ (forward) and 5’- 
CGCGTCCCCGCGAGCTGCACTGCC-3’ (reverse) were used.  These PCR 
products were TA cloned into pCR2.1 (Invitrogen) and transformants were 
screened for inserts.  The pCR2.1 vector carrying 5’ UTR insert was then 
digested with EcoRI, separated on a 2% agarose gel, and the inserts were gel 
purified (Qiagen).  These 5’ UTR inserts were then ligated to EcoRI cut C49 
backbone, and colonies were screened for inserts.  Colonies lacking an insert 
were sequenced and used as a negative control (C49 -).  Vectors containing the 
5’ UTR insert were sequenced to determine correct directionality of the ligated 
insert (Operon).  Finally, point mutations were introduced to the C49 mmPdxUTR 
construct to eliminate uORFs using a Site Directed Mutagenesis kit (Agilent) to 
mutate upstream ATG codons to AGG codons. 
 
2.2 METHODS 
A. Cell Cycle Analysis 
 Approximately 106 cells were harvested by trypsinization, washed twice in 
PBS, and resuspended in ice-cold 70% ethanol.  Cells were then washed twice in 
PBS, resuspended in Guava cell cycle reagent (Guava Technologies), and 
incubated at room temperature for 30 minutes.  Cell cycle phase was then 
determined via FACS analysis using a Beckman Coulter FC500 flow cytometer 
and FloJo data analysis software. 
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B. Cytokine and Inhibitor Treatment 
 Islet or cell cultures were treated at 37oC with a cytokine cocktail 
containing 5ng/ml IL-1, 10ng/ml TNF-, and 100ng/ml IFN- (Prospec) for the 
indicated times.  Cell cultures and islets were treated with 1@M thapsigargin (a 
SERCA inhibitior and inhibitor of translation initiation) at 37oC for the indicated 
times.  Inhibitors to MAPKs p38 (PD169316) and JNK (SP600125) were used at 
a final concentration of 10@M, the iNOS inhibitor L-NMMA was used at a final 
concentration of 1mM, and the DHS inhibitor GC7 (see Chapter 1.6C) was used 
at a final concentration of 100@M.  Cycloheximide (CHX), an inhibitor of 
translational elongation, was used at a concentration of 50@g/ml.  
 
C. Dual Luciferase Assay 
 Following transfection of luciferase expressing constructs, luciferase 
activity was determined using a commercially available dual luciferase activity kit 
(Promega) and luminometer (Turner BioSystems).  Approximately 106 luciferase 
transfected MIN6  cells were washed with PBS, then lysed in 500@l passive 
lysis buffer for 15min at RT, spun at 13,000 x g for 1min, and the cleared lysate 
was moved to a new tube.  Luciferase assay reagent II (LARII) and Stop & Glo 
reagent (Promega) were used to prime the luminometer.  Using a luminometer 
program (Turner BioSystems), 100ul of LARII was added to 20@, of cell extract, 
and firefly luciferase activity was evaluated.  Next, 100ul of Stop & Glo reagent 
was then added, and renilla luciferase activity was determined. 
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D. Glucose Tolerance Test 
 Mice were fasted overnight and injected intraperitoneally with 2g 
glucose/kg body weight.  Blood was sampled from the tail vein at 0, 10, 20, 30, 
60, 90, and 120 minutes post injection, and blood glucose was measured from 
whole blood using the AlphaTrak blood glucose monitoring system (Abbott 
Laboratories). 
 
E. 3H-Spermidine Incorporation Assay 
 To assess the activity of DHS in vitro, we measured 3H-spermidine 
incorporation into hypusine-eIF5A.  Approximately 100 islets or 106 MIN6 or INS1 
 cells were incubated with 1.5@Ci [3H] spermidine (PerkinElmer) per ml culture 
for 4h at 37oC.  Whole cell extracts were then isolated and subjected to 12% 
SDS-PAGE.  Gels were fixed for 30min in a solution containing 10% acetic acid 
and 30% methanol, transferred to En3HANCE autoradiography enhancer solution 
(Perkin Elmer) for 1h, and to 10% polyethylene glycol for 30min, dried for 1h in a 
gel dryer and vacuum pump (Biorad), and visualized by fluorography.  Band 
intensity was quantified using ImageJ Software (NIH). 
 
F. 3H-Thymidine Incorporation Assay 
 Proliferation was assessed via incorporation of 3H-thymidine into genomic 
DNA of MEFs.  Approximately 106 cells were incubated with 1@Ci [3H] methyl-
thymidine (Perkin Elmer) for 4h, washed with cold PBS, and DNA was 
precipitated with cold 10% trichloroacetic acid for 15min, and solubilized with 
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0.3N NaOH for 30min.  Amount of [3H] thymidine incorporation was measured 
using liquid scintillation counting, and was normalized to protein content. 
 
G. 35S-Cystein/Methionine Incorporation Assay 
 For 35S-Cys/Met uptake assays, approximately 106 MIN6 cells were 
cultured in 6 well plates in the presence or absence of cytokines for 24 or 72 h, 
then 100 µCi of a mixture of 35S-Met and 35S-Cys (Perkin Elmer) was added for 
one hour.  The medium was removed, and cells were washed 3 times with PBS 
containing 1 mM Met and 1 mM Cys (Sigma), then lysed in SDS loading buffer.  
A fraction of the lysate was counted on a scintillation counter to correct for 35S 
amino acid uptake, and corrected lysate volumes were subjected to 4-20% SDS-
PAGE.  The gel was dried as discussed previously, and visualized by 
fluorography. 
 
H. Immunoblot Analysis 
 Whole cell extracts from MIN6  cells, INS1  cells, and islets were 
collected in lysis buffer containing 10% glycerol, 0.1% NP-40, 0.05% 
deoxycholate, 50mM Tris-HCl, 10mM NaF, 1mM EDTA, and 1mM DTT and 
supplemented with protease and phosphatase inhibitors (Roche).  Immunoblot 
analyses of cell extracts were performed after separation of 15@g of protein 
extract by 4-20% gradient SDS-PAGE (Invitrogen).  Protein was transferred to a 
fluorescence compatible PVDF membrane (Millipore) using a wet transfer 
apparatus (BioRad).  Membranes were blocked with Odyssey blocking buffer 
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(LiCor Biosciences), and incubated overnight at 4oC with primary antibodies.  
Immunoblots were then washed with 0.05% Tween 20 in PBS, incubated with 
fluorophore labeled secondary antibodies for 1h at RT, and washed with PBS.   
Immunoblots were visualized using a Li-Cor Odyssey fluorescent imaging system 
(Li-Cor Biosciences) and blot intensity was quantified using ImageJ software.   
  
I. Polyribosomal Profiling 
 PRP experiments in MIN6  cells, INS1  cells, and islets were conducted 
as described previously (41).  Cells were grown to 70% confluency in 100mm 
tissue culture dishes, and washed twice with cold PBS containing 50>g/ml 
cycloheximide (CHX, Sigma-Aldrich) and harvested in 500>l of lysis buffer 
containing 20mM Tris-HCl (pH 7.5), 10mM MgCl2, 100mM NaCl, 1% Triton X-
100, 50U/mL recombinant ribonuclease inhibitor RNasin (Promega), and 50>g/ml 
CHX.  The cell lysates were passed through a 23-gauge needle and incubated 
on ice for 10 min, followed by centrifugation at 13,000 x g for 10 min at 4oC.  A 
portion of the lysate supernatant was preserved as the input sample to determine 
total mRNA levels.  Supernatant (400>. was then added onto a 10-40% sucrose 
gradient solution containing 20mM Tris-HCl (pH 7.5), 5mM MgCl2, 100mM NaCl, 
and 50>g/ml CHX.  The sucrose gradients were subjected to centrifugation at 
4oC in a Beckman SW-41Ti rotor at 40,000rpm for 2h.  A piston gradient 
fractionator (BioComp) was used to fractionate the gradients, and absorbance of 
RNA at 254 nm was recorded using an in-line UV monitor (BioRad).  The eluate 
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was collected using a fraction collector, and total RNA from the fractions was 
purified (Qiagen), reverse transcribed, and subjected to qRT- PCR. 
 
J. Transfection 
 Transient transfections were performed using 70% confluent MIN6  cells 
in a 6-well tissue culture dish.   For translation studies, 2 ?g of reporter plasmid 
(C49 constructs) was combined with 6 ?l of Metafectene reagent (Biontex) and 
added to cells in Pen/Strep free media for 6h.  Transfection media was then 
removed, and growth media was returned to the cultures. Cells were harvested 
24h after transfection, and prepared for either RNA isolation or protein extraction. 
 
K. Quantitative Real-Time Reverse Transcriptase (RT)-PCR 
 Approximately 106  cells or 50-100 islets were lysed in 350ml of Buffer 
RLT (Qiagen) containing 1% -mercaptoethanol.  Samples were sheared through 
a 27-gauge needle, and total RNA was recovered using Qiagen RNAEasy 
columns.  Total RNA was reverse transcribed to make cDNA and subjected to 
qRT-PCR using SYBR Green as described previously (162). 
Samples were normalized to Actb message levels, except in the case of RNA 
from polyribosomal profiling experiments, which were reported as the percent of 
total recovered RNA.  All data represent the mean of triplicate determinations 
from at least three independent experiments of  cells or pooled mouse islets 
from three separate isolations.  Primers previously described include Bip, Xbp1, 
Xbp1s, and Chop, Serca2b, ATF4, and Pdx1 (41).  For amplification of Actb, the 
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following primers were used: 5’- AGGTCATCACTATTGGCAACGA-3’ (forward) 
and 5’-CACTTCATGATGGAATTGAATGTAGTT-3’ (reverse).  For Nos2, the 
following primers were used: 5’- CCTACCAAAGTGACCTGAAAGAGG-3’ 
(forward) and 5’- ATTCTGTGCTGTCCCAGTGAGGAG-3’ (reverse). For Cpe, the 
following primers were used: 5’- GCTCAGGTAATTGAAGTCTT-3’ (forward) and 
5’- TACTGCTCACGAATACAGTT-3’ (reverse).  For firefly luciferase, primers 5’- 
AGAGGATGGAACCGCTGGAGAG-3’ (forward) and 5’- 
GCTTCTGCCAACCGAACGGAC-3’ (reverse) were used.  For renilla luciferase, 
primers 5’- CAAAGAGAAAGGTGAAGTTCGTCG-3’ (forward) and 5’-
TGGAAAAGAATCCTGGGTCCG-3’ (reverse) were used. 
 
L. Statistics 
 All data are presented as the mean ± SEM.  One-way ANOVA (followed 
by a Dunnett’s post test) was used for comparisons in which two or more 
conditions were compared with a single control, and a Student’s t test was 
performed where one condition was compared with a single control (using 
Bonferonni post test).  Prism software version 5.0 (GraphPad) was used for all 
statistical analyses.  Statistical significance was defined as P < 0.05. 
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CHAPTER 3 
Maintenance of Pdx1 mRNA Translation in Islet  Cells During the 
Unfolded Protein Response 
 
 In this chapter, I explore changes to the translational status of islet  cells 
in response to known ER stress and UPR inducing agents, including 
proinflammatory cytokines.  Particular emphasis is placed on investigating 
regulation of translation initiation in the islet  cell stress response.  Experiments 
using palmitate were carried out in collaboration with Dr. Masayuki Hatanaka at 
Indiana University School of Medicine.    
 
3.1 INTRODUCTION 
 As discussed previously, pancreatic  cells are exposed to 
proinflammatory cytokines in the setting of both T1D and T2D, causing  cell 
dysfunction and death (see Chapter 1.3D) (55,60).  Little is currently known 
about how translational responses may contribute to such  cell failure.  To study 
mRNA translation responses as seen in diabetes, I first established physiologic 
cell culture conditions that mimic the UPR.  Previously, it was reported that early 
UPR is observed upon incubation of  cells and islets with a mixture of 
proinflammatory cytokines for 24h (89,90).  Here, I investigate cytokine induced 
translational changes in islet  cells, and compare these changes to overt ER 
stress.  In addition to assessment of general  cell translational status, I explore 
translational regulation of Atf4, Chop, Cpe, and Pdx1 in  cells exposed to known 
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UPR inducers.  Finally, I assess the ability of the Pdx1 5’ UTR to mediate stress 
resistant translation.  As a positive control for ER stress, cells were treated with 
thapsigargin (an inhibitor of the SERCA Ca2+ pump) for 4h.   
 
3.2 RESULTS  
A. Proinflammatory cytokines activate the UPR in MIN6  cells and mouse 
islets 
 As shown in Fig. 8A, treatment of both MIN6 cells and mouse islets with 
thapsigargin led to clear increases in the ER stress markers Atf4, Chop, and 
spliced Xbp1, with increases in corresponding proteins levels of ATF4 and CHOP 
(Fig. 8B).  In contrast to the overt effect of thapsigargin, treatment of MIN6 cells 
with cytokines for 24h led to significant increases in spliced Xbp1 and Chop, but 
not Atf4 mRNA, with similar findings in mouse islets.  Despite the minimal 
changes to Atf4 mRNA seen with cytokine incubation, I observed a significant 
increase in the protein levels of ATF4 in both MIN6 cells and islets (but not 
CHOP) (Fig. 8B), consistent with the known effect of the UPR to enhance Atf4 
mRNA translation (177).  I next examined the mRNA and protein levels of factors 
thought to be suppressed by the UPR.  The levels of the mRNA encoding the 
insulin processing enzyme carboxypeptidase E (Cpe) were unchanged in MIN6 
cells and islets (Fig. 8A) at 24 h cytokine incubation, yet its protein levels were 
reduced (Fig. 8B), consistent with the known UPR-mediated suppression of this 
protein (178). Together, these data indicate proinflammatory cytokines induce ER 
stress and the appropriate UPR in MIN6  cells and mouse islets. 
 52 
   
 
Figure 8: Proinflammatory cytokines activate the UPR in mouse MIN6 cells 
and islets.  A, MIN6 cells (top panel) or mouse islets (bottom panel) were 
untreated (CTL), treated with cytokines (5ng/ml IL-, 10ng/ml TNF-, 100ng/ml 
IFN-) for 24h, or with 19M thapsigargin (Tg) for 4h.  cDNA from total cell lysates 
were subjected to qRT-PCR for the genes indicated. B, total cell lysates from 
MIN6 cells (top panel) or mouse islets (bottom panel) were subjected to 
immunoblot analysis following 24h cytokines or 4h thapsigargin treatment, and 
results were quantified and displayed in bar graphs.  Data represent means ± 
SEM.  n=3-5. *P<0.05 compared to CTL.  
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B. Early effects of proinflammatory cytokines on translational regulation in 
MIN6 tiony cytokines ment, an  
 In the setting of ER stress, the UPR attempts to mitigate new protein 
production in part via inhibition of translation.  The phosphorylation of eIF2 by 
PERK leads to a block in the initiation of new mRNA translation (179).  To assess 
the effects of cytokines and thapsigargin on mRNA translation, I subjected MIN6 
cells and islets to polyribosomal profile (PRP) experiments, as outlined in Fig. 9 
(180).  Briefly, lysates were added atop a 10-50% sucrose gradient and 
sedimented by ultracentrifugation.  Sedimented gradients were then subjected to 
measurement of RNA absorbance, and factions were collected to assess 
changes to ribosomal occupancy of specific RNAs (Fig. 9).  As shown in Fig. 10A 
and B (and in agreement with prior studies, ref. (89)), cytokine treatment of MIN6 
cells and islets led to an increase in eIF2 phosphorylation (similar, but slightly 
lower in magnitude compared to thapsigargin).  Fig. 10A shows typical PRPs for 
MIN6 cells treated with and without thapsigargin, showing the positions of the 
80S monoribosome-associated (initiating or inactively translating) RNAs and the 
polyribosome-associated (actively translating) RNAs.  Compared to untreated 
cells, thapsigargin treatment resulted in the relative depletion of polyribosome-
associated RNA compared to monoribosome-associated RNA (reflected as a 
reduced polyribosome/monoribosome—P/M—ratio of 0.892 ± 0.18 vs. 0.547 ± 
0.1, P<0.05). This finding is consistent with the known effects of ER stress, as a 
block in translation initiation causes retention of monoribosomes as 
polyribosomes elongate and run off of RNA transcripts (180).  By contrast, the 
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PRP of primary islets (Fig. 10B) shows general predominance of 80S 
monoribosomes, with little change in the P/M ratio following 24 h of thapsigargin 
treatment (P/M ratio of 0.999 ± 0.15 vs. 0.819 ± 0.03, P=NS).  Upon treatment 
with cytokines for 24h, neither MIN6 cells nor islets showed change in the P/M 
ratio. Overall, these data indicate that the early effect of cytokines to activate the 
UPR is not evident from examination of the PRP.  
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Figure 9: Polyribosomal profiling (PRP) reveals changes to ribosomal 
occupancy of RNA.  Polyribosomal profiling (PRP) facilitates analysis of 
translation via assessment of ribosomal occupancy of total RNA as well as 
specific RNAs.  Cell or islet total cell lysates were added atop a 10-50% sucrose 
gradient, and sedimented at 270,000g for 2h.  A piston gradient fractionator was 
used to fractionate the gradient, while an in-line UV monitor measured RNA 
absorbance at 254nm.  This data indicates the general translational status of  
cells, as measured by ratio of polyribosome associated RNA.  Ten fractions per 
gradient were collected, and total RNA was isolated, reverse transcribed, and 
subjected to qRT-PCR for each fraction.  This data indicates how ribosomal 
occupancy of specific transcripts changes in response to stress.  
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Figure 10:  Early effects of proinflammatory cytokines on translational 
regulation in MIN6  cells and mouse islets.  A, MIN6  cells were untreated 
(CTL), treated with cytokines (Cyto) for 24h, or treated with 11M thapsigargin 
(Tg) for 4h, then subjected to immunoblot analysis for eIF2 phosphorylation (top 
panel), or PRP analysis (bottom panel); B, as in panel A, with mouse islets.  
Representative data from 3 independent experiments are shown for each. 
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C. Prolonged exposure to proinflammatory cytokines induces an apparent 
block in translational initiation 
 ER stress triggers the PERK-mediated phosphorylation of eIF2, causing 
a block in the translational initiation of most cellular mRNAs in an attempt to 
decrease ER protein load (179,181).  Because cytokine release from adipocytes 
and from infiltrating immune cells is believed to contribute to islet dysfunction and 
reduced insulin release from islets in type 2 and type 1 diabetes respectively, I 
asked whether prolonged exposure of cells to cytokines causes a translational 
initiation block, consistent with the ER stress response.  To assess the 
translational effects directly, I performed PRP.  Fig. 11A shows the positions of 
the 40S, 60S, and 80S ribosomal species, as well as polyribosomes (which 
contain multiple ribosomes bound to individual transcripts) from the total RNA of 
control MIN6 cells.  The ratio of polyribosomes to 80S monoribosomes (P/M 
ratio) is 1.59 in these control cells.  A 4-hour treatment of MIN6 cells with 1 µM 
thapsigargin (a SERCA pump inhibitor and inducer of ER stress) results in the 
dissipation of the polyribosome fraction and a decrease in the P/M ratio to 0.85, 
consistent with a block in initiation and a resultant runoff of polyribosomes (Fig. 
11A).  This ribosomal runoff and fall in the P/M ratio is considered a hallmark of 
translation initiation blockade (179).  During a timecourse of treatment of MIN6 
cells with a cocktail of cytokines (IL1-, TNF-, and IFN-), there was a gradual 
loss of the polyribosomal fraction and a decrease in the P/M ratio that occurred 
after 24 hours (Fig. 11B).  To verify that this loss of polyribosomes resulted in a 
decrease in total protein synthesis, I incubated MIN6 cells with cytokines for 0, 
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24, or 72 hours, then with a mixture of 35S-Met and 35S-Cys for 1 h.  As shown in 
Fig. 11C, after loading correction for total cellular uptake of 35S, cytokine 
treatment resulted in a global decrease in total 35S incorporation into protein at 
72h.  Further, blockade of translation initiation in this model is not attributable to 
the effects of iNOS, as co-incubation with the NOS inhibitor L-NMMA (1mM) did 
not result in retention of polyribosome associated mRNA (Fig. 11D).  These data 
demonstrate that prolonged proinflammatory cytokine treatment results in a 
decrease in protein synthesis and polyribosome associated RNAs, consistent 
with blockade of translation initiation and ER stress. 
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Figure 11:  Prolonged exposure to proinflammatory cytokines induces an 
apparent block in translational initiation.  MIN6 cells were treated with 15M 
thapsigargin, or cytokines for the indicated times, and subjected to PRP or 35S-
Cys/Met incorporation.  A, polyribosomal profiles of MIN6 cells untreated or 
treated with thapsigargin; B, profiles of MIN6 cells treated with cytokines for the 
indicated times; polyribosome to monoribosome (P/M) ratios are indicated for 
each condition; C, proteins labeled with 35S-Cys/Met for 1 hour after cytokine 
treatment were subjected to SDS-PAGE analysis to compare total protein 
synthesis;  D, MIN6 cells were coincubated with cytokines and the NOS inhibitor 
L-NMMA for the indicated times, and subjected to PRP.  Representative data 
from 3 independent experiments are shown for each. 
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D. Chronic palmitate incubation increases markers of the UPR and reduces 
polyribosome-associated RNAs in  cells 
 In addition to proinflammatory cytokines, we undertook experiments to 
determine the effects of saturated free fatty acids on  cell translation.  Saturated 
FFAs have been shown to activate the unfolded protein response (UPR), leading 
to ER stress and  cell dysfunction (2).  As shown in Fig. 12A, mRNA markers of 
UPR activation including spliced Xbp1, Bip, Atf44, and Chop are increased at 
72h after palmitate incubation in MIN6 cells (at levels at or below those seen with 
4h of thapsigargin incubation).  To study the effects of saturated FFAs on mRNA 
translation in  cells, we incubated MIN6  cells with 0.5mM palmitate and 
subsequently performed PRP analysis.  The normal PRP of MIN6  cells is 
shown in Fig. 12B, and is identified with a solid line.  After 72h of palmitate 
addition, there was a decrease in the fraction of RNAs associated with 
polyribosomes (Fig. 12B, dashed line), which was reflected by a decreased P/M 
ratio (Fig. 12B).  As shown in Fig. 12C, palmitate incubation of MIN6 cells led to 
increases in phosphorylated eIF2 with time.  Incubation of MIN6  cells for 4 h 
with 1 µM thapsigargin, a very potent inducer of phosphorylated eIF2 and the 
UPR, resulted in a similar reduction in the P/M ratio (Fig. 12D), accompanied by 
increases in phosphorylated eIF2 (Fig. 12E).  The results in Fig. 12 collectively 
indicate that palmitate causes a progressive reduction in global translation 
initiation that is consistent with activation of the UPR. 
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Figure 12:  Chronic palmitate incubation increases markers of the UPR and 
reduces polyribosome-associated RNAs  cells.  A, MIN6  cells were 
untreated, treated with palmitate for 1h or 72h, or treated with thapsigargin for 4h, 
and cDNA from total cell lysates were subjected to qRT-PCR for the indicated 
genes; MIN6  cells were treated with palmitate for 72h (B) or with thapsigargin 
for 4h (D), then subjected to PRP analysis for P/M ratio quantification; MIN6 cells 
were treated with palmitate for the indicated times (C) or with thapsigargin for 4h 
(E), then subjected to immunoblot analysis for quantification of phospho-eIF2.  
Data represent means ± SEM.  n  3. *P<0.05 compared to CTL. 
 
 
  
0.00
0.05
0.10
0.15
0.20
0.25
*
1h 24h4h
CTL PAL
72h
*
*
p-
eI
F2

/e
IF
2
 le
ve
l
 
Sedimentation
To
ta
l R
N
A
 (A
25
4)
0
2
4
6
8
10
CTL Tg
*
P/
M
 ra
tio
Sedimentation
To
ta
l R
N
A
 (A
25
4)
0
1
2
3
4
CTL PAL
*
P/
M
 ra
tio
0
1
2
3 *
CTL Tg
p-
eI
F2
 
/to
ta
l e
IF
2
C CTL PAL
1h
p-eIF2
eIF2
CTL
p-eIF2
eIF2
Tg
CTL PAL
4h
CTL PAL
24h
CTL PAL
72h
E F
CTL
Tg
CTL
PAL
D
A
Bip
0
2
4
6
* *
C P
1 h
C P
72 h
C TgRe
la
tiv
e 
ex
pr
es
si
on
 le
ve
l
Xbp1s
0.0
0.5
1.0
1.5
2.0
2.5
8
9
10
11
*
*
C P
1 h
C P
72 h
C TgRe
la
tiv
e 
ex
pr
es
si
on
 le
ve
l
Atf4
0
1
2
3
4
5 * *
C P
1 h
C P
72 h
C TgRe
la
tiv
e 
ex
pr
es
si
on
 le
ve
l
Chop
0
1
2
3
4
8
10
12
*
*
C P
1 h
C P
72 h
C TgRe
la
tiv
e 
ex
pr
es
si
on
 le
ve
l
ED
CB
 62 
E. Proinflammatory cytokines activate Atf4 and Chop translation, and 
repress Cpe translation in MIN6  cells 
 In our cytokine and FFA treated MIN6 models of translational regulation, 
we observed elevated eIF2 phosphorylation prior to loss of polyribosome 
associated RNAs.  I hypothesized that the PRPs (which reflect total RNA 
engagement at ribosomes) may be relatively insensitive to the translational 
events induced by stressors at early time points, and that alterations in 
engagement of specific mRNAs with polyribosomes may be more evident.  To 
examine specific mRNA engagement with mono- and polyribosomes, I next 
performed real-time qRT-PCR from individual PRP fractions to quantitate 
changes in ribosome association.  I found that Atf4 mRNA was shifted rightward 
toward greater occupancy by polyribosomes following proinflammatory cytokine 
treatment—similar to thapsigargin treatment—suggesting increased ribosome 
engagement and mRNA translation under these conditions (Fig. 13A).  This shift 
towards polyribosomes is in agreement with the increased protein levels of ATF4 
observed under ER stress conditions (Fig. 8B).  Similarly, I observed a rightward 
shift of Chop mRNA towards polyribosomes with cytokine and thapsigargin 
treatments (Fig. 13B).  These data suggest that the established mechanism of 
phospho-eIF2n mediated translational activation of Atf4 and Chop via uORF is 
conserved in the islet  cell.  In contrast, Cpe mRNA showed a leftward shift into 
monoribosomes under both cytokine and thapsigargin conditions (Fig. 13C), 
consistent with reduced engagement of translating ribosomes and reduced 
carboxypeptidase E levels (Fig. 8B).  This data supports recent evidence that 
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Cpe translation is stress sensitive and is regulated by a cap-dependent 
mechanism (132).  These data suggest that proinflammatory cytokines, similar to 
thapsigargin, induce differential effects on mRNA translation depending upon the 
nature of the transcript. 
 
F. Palmitate activates Atf4 translation in MIN6  cells 
 A classic feature of saturated FFA induced  cell dysfunction is activation 
of the UPR.  Consistent with this idea, 24h palmitate treatment of MIN6  cells 
revealed a shift of Atf4 mRNA from monoribosome fractions to polyribosome 
fractions (Fig. 14A).  This change is comparable to that seen with thapsigargin 
treatment, and indicates a palmitate induced translational activation of Atf4 (Fig. 
14B). 
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Figure 13:  Proinflammatory cytokines activate Atf4 and Chop translation, 
and repress Cpe translation MIN6  cells.  MIN6  cells were untreated (CTL), 
treated with cytokines for 24h (Cyto), or with thapsigargin for 4h (Tg), and 
subjected to PRP analysis with fractionation of the sedimentation gradient; A, 
analysis of Atf4 mRNA in PRP fractions; B, analysis of Chop mRNA in PRP 
fractions; C, analysis of Cpe mRNA in PRP fractions.  Representative data are 
shown on the left of panel A, B, and C, and the percent of total mRNA in 
polyribosomes is quantified on the right.  Data represent mean ± SEM.  n=3-5. 
*P<0.05 compared to CTL. 
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Figure 14: Palmitate activates Atf4 mRNA translation in MIN6  cells.  MIN6 
 cells were treated with palmitate for 72h (A), or with thapsigargin for 4h (B), and 
subjected to PRP analysis with fractionation of the sedimentation gradient; A, 
analysis of Atf4 mRNA in PRP fractions following palmitate treatment (open 
circles); B, analysis of Atf4 mRNA in PRP fractions following thapsigargin 
treatment (open circles).  Data represent means ± SEM.  n  3. *P<0.05 
compared to CTL.  
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G. Pdx1 mRNA maintains ribosomal occupancy in the setting of the UPR 
 Pdx1 was recently shown to activate genes necessary for the adaptive 
UPR.  Thus, I hypothesized that Pdx1 mRNA translation must be maintained as a 
requisite for adaptation to ER stress (32).  As shown in Fig. 15A and B, neither 
Pdx1 mRNA nor Pdx1 protein levels changed following 24h treatment with 
cytokines or 4h treatment with thapsigargin in MIN6 cells.  In spite of the 
phosphorylation of eIF2 under these conditions, the association of Pdx1 mRNA 
with polysomes was unchanged following both cytokine and thapsigargin 
treatment (Fig. 15C).  These data suggested to us that Pdx1 mRNA translation 
was maintained by mechanisms that are distinct from those that suppress 
translation of Cpe, or that enhance translation of Atf4 and Chop.  
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Figure 15: Pdx1 mRNA retains ribosomal occupancy in the setting of the 
UPR.  MIN6  cells were untreated (CTL), treated with cytokines for 24h (Cyto), 
or with thapsigargin for 4h (Tg), then subjected to qRT-PCR, immunoblot 
analysis, or PRP analysis with fractionation of the sedimentation gradient.  A, 
qRT-PCR analysis from whole cell extracts; B, immunoblot analysis (top panel), 
with corresponding quantification (n=3-5, lower panel); C, qRT-PCR analysis of 
Pdx1 mRNA in PRP fractions (left panel), and corresponding quantification of 
percent of total mRNA in polyribosomes.  Data represent mean ± SEM, n=3-6. 
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H. The Pdx1 mRNA 5’-UTR enhances mRNA translation in the setting of the 
UPR  
 mRNAs containing a 5’-7 methylguanylate “cap” are targeted for eIF2 
dependent translation initiation, and are translationally repressed when eIF2 is 
phosphorylated during the UPR (182).  Many privileged mRNAs contain elements 
in the 5’-UTR that aid in ribosome recruitment and initiation under conditions of 
stress (see Chapter 1.6A) (182).  To investigate if the maintenance of Pdx1 
mRNA translation during the UPR is governed by its 5’-UTR, I cloned the 5’-UTR 
of the mouse Pdx1 gene into a bicistronic luciferase reporter vector (C49) 
between the renilla and firefly luciferase genes (176).  This vector allows the 
expression of the first gene (renilla luciferase) to be driven by conventional, cap-
dependent translation initiation, while expression of the second gene (firefly 
luciferase) is driven by cap-independent translation initiation mediated by the 
cloned 5’-UTR element(s) (Fig. 16A).  Upon transfection of the bicistronic 
reporter constructs into cell lines, the ratio of the firefly:renilla luciferase activity is 
a gauge of intrinsic ribosome initiation activity (176).   
 As shown in Fig. 16B, the mouse Pdx1 mRNA 5’-UTR showed ~15-fold 
enhancement of the firefly:renilla activity ratio in MIN6 cells compared to an 
empty vector control or to a bicistronic vector containing the Cpe 5’-UTR (Fig. 
16B).  Mouse Pdx1 mRNA 5’-UTR also displayed a ~5-fold enhancement of 
firefly:renilla activity ratio compared to the human surfactant protein A (hSPA) 5’-
UTR, which contains a known internal ribosomal entry site (176).  To determine if 
the human PDX1 5’ UTR also directed cap-independent translation, I inserted the 
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human PDX1 5’-UTR into the bicistronic reporter vector.  The human PDX1 5’-
UTR showed a ~65-fold enhancement of the firefly:renilla luciferase activity ratio 
in MIN6  cells compared to empty vector control (Fig. 16B).  Importantly, the 
increased firefly:renilla activity ratios with the human and mouse 5’-UTRs were 
not caused by a cryptic promoter element, because ratios of firefly:renilla 
luciferase mRNAs by real-time PCR were identical for all constructs tested (Fig. 
16C).  Next, I carried out these experiments under cytokine and thapsigargin 
treated conditions to determine if translational enhancement persists under 
stress conditions.  As shown in Fig. 17, the Pdx1 5’-UTR continues to 
significantly drive firefly:renilla activity at a level comparable to that of hSPA, 
which contains an internal ribosomal entry site.  However, the firefly:renilla 
activity ratio was reduced approximately 3 fold under conditions of cytokine 
stress (Fig. 16B and Fig. 17A).  Collectively, the data in Figures 15-17 indicate 
that Pdx1 5’-UTR drives cap-independent translation of downstream ORFs and 
that its activity is comparable to that of known internal ribosomal entry sites under 
conditions of ER stress. 
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Figure 16: Pdx1 5’ UTR allows cap-independent translation initiation of 
downstream ORFs.  A, schematic diagram of the bicistronic reporter vector, 
showing positions of the SV40 promoter, renilla luciferase gene (RLuc), 5’ UTR, 
and firefly luciferase gene (FLuc); B, MIN6 cells were transfected with bicistronic 
vector containing no insert (empty vector), 5’ UTR of hSPA, 5’UTR of Cpe, and 
5’UTRs of mouse and human Pdx1 genes, then subjected to dual luciferase 
assay; C, same as in panel B, except that cDNA from each condition was 
subjected to qRT-PCR for firefly and renilla mRNAs (normalized to Actb mRNA).  
Data represent mean ± SEM.  n=3-8.  *P<0.05 compared to empty vector. 
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Figure 17: Pdx1 5’ UTR facilitates cap-independent translation in the setting 
of the UPR.  MIN6  cells were transfected with the bicistronic reporter vectors 
containing no insert (empty vector), hSPA, Cpe, or mouse Pdx1 5’UTRs, then 
treated with cytokines for 24h, or thapsigargin for 4h, and subjected to dual 
luciferase assay.  A, results after cytokine treatment; B, results after thapsigargin 
treatment.  Data represent mean ± SEM.  n=3-8.  *P<0.05 compared to empty 
vector.  
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I. Upstream open reading frames (uORFs) in the Pdx1 5’-UTR are not 
required for enhanced mRNA translation 
 Recent studies suggest that upstream open reading frames (uORFs) in 
the 5’ UTR may play permissive or inhibitory roles in the translation of certain 
physiologic downstream ORFs (142).  As shown in Fig. 18A, comparison of 
mouse and human Pdx1 5’-UTRs revealed 70% identity and the existence of a 
conserved uORF beginning at bp –171(mouse) and at bp –187 (human) relative 
to the protein coding translation start site.  Deletion analysis of the Pdx1 5’ UTR 
was carried out using the constructs outlined in Fig. 18B.  Deletion of the 
proximal region of the mouse 5’ UTR, including a proximal portion of the uORF 
(deletion mutant 1 - DM1), did not affect reporter activity, leading us to 
hypothesize that translation of this uORF is not required for enhanced translation 
of the coding ORF (Fig. 18C).  Conversely, deletion of the distal region of the 5’ 
UTR (containing the uORF start site, deletion mutant 2 - DM2) led to complete 
loss of the ability of the element to enhance translation of firefly luciferase in both 
the mouse and human element (Fig. 18C), suggesting that the region –105 to –
280 contains elements that promote translation.  Notably, these alterations in 
firefly:renilla activity ratios were not caused by changes in firefly:renilla message 
(Fig. 18D).  Together, these data indicate that elements in the distal portion of the 
Pdx1 mRNA 5’ UTR are required for full activity of this translation enhancing 
element.  
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Figure 18: Deletional analysis of the Pdx1 5’ UTR.  A, line-up of mouse and 
human Pdx1 5’ UTRs, showing in gray the poitions of putative uORFs; B, 
schematic representation of deletion mutants of the mouse and human Pdx1 5’ 
UTR that were inserted into the bicistronic vector between the renilla luciferase 
(RLuc) and firefly luciferase (FLuc) genes; C, results of dual luciferase assays 
following transfection of the constructs in panel B into MIN6  cells; D, qRT-PCR 
from total RNA for renilla luciferase and firefly luciferase mRNAs (normalized to 
Actb mRNA).  Data represent mean ± SEM.  n=3-8.  *P<0.05 compared to empty 
vector. 
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3.3 DISCUSSION 
 In T1D, protein unfolding and ER stress in the  cell is thought to arise 
when local or generalized inflammation (arising from innate or adaptive immune 
processes) triggers pathways that lead to nitric oxide production, oxidative stress, 
and/or reductions in SERCA2 levels (183).  In T2D, proinflammatory cytokines, 
free fatty acids, and insulin resistance disrupt  cell ER homeostasis.  Under 
these conditions, the UPR induces generalized reductions in mRNA translation 
initiation, along with a simultaneous increase in translation of specific mRNAs 
needed for stress remediation (182).  In these studies, I examined the differential 
 cell translational responses to known ER stressors.  I observed changes to 
ribosomal occupancy of total cell RNA, as well as to key stress-responsive 
mRNAs in the  cell.   
 The translational regulation of mRNAs occurs predominately at the level of 
translation initiation, where factors including eIF2, eIF4E, and the eIF4F 
complex control initiation (137,150).  Under conditions of fuel excess, pathways 
such as the mammalian target of rapamycin (mTOR) promote eIF4E activity to 
enhance translation initiation (184).  By contrast, under conditions of stress, such 
as during fuel (amino acid) deficiency or ER stress, translation of many 5’-7-
methylguanylate-“capped” transcripts is repressed at the level of initiation (182).  
This repression is mediated by eIF2 phosphorylation and availability and 
assembly of cap binding translation factors.  In the  cell, it was recently shown 
that translation of mouse Cpe mRNA is dependent upon the cap component 
eIF4G1 for continued translation, and is subject to translational repression under 
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conditions of ER stress (132).  By contrast, other mRNAs are translationally 
activated during stress.  Atf4 and Chop mRNA each contain inhibitory upstream 
open reading frames (uORFs) that repress translation of the downstream coding 
ORF under normal conditions.  Under conditions of ER stress, however, initiation 
at these uORFs is repressed, while translation from the coding ORF 
predominates (127,185).   
 Our studies demonstrate that both activation and repression of translation 
initiation is pertinent to  cell physiology under ER stress, and that physiological 
stressors including proinflammatory cytokines and free fatty acids are sufficient to 
induce such translational control.  With respect to global  cell translation, 
chronic exposure of  cells to proinflammatory cytokines resulted in loss of 
polyribosome associated RNAs, suggestive of a translation initiation block 
consistent with ER stress (Fig. 10-11).  Interestingly, whereas thapsigargin 
causes rapid shut-down of global translation initiation (hours), I did not observe 
this until after prolonged cytokine treatment (days), indicating important 
differences in the effects of thapsigargin and cytokines on  cell translation.  
 In addition to causing a rapid shut down of general translation initiation in 
 cells, thapsigargin concurrently activates translation of Atf4 and Chop in MIN6 
 cells, increasing expression of these proteins.  I next examined translational 
activation of Atf4 and Chop in response to proinflammatory cytokine treatment.  
In contrast to thapsigargin treatment, I observed cytokine-induced changes to 
ribosomal occupancy and protein expression of Atf4, Chop, and Cpe, prior to 
changes in global translation as assessed by PRP analysis.  These findings 
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indicate that physiological stressors such as cytokines induce translational 
regulation of specific transcripts via eIF2 phosphorylation prior to a global shut 
down of translation initiation. Such responses may be critical to an appropriate  
cell stress response. 
 These studies are among the first to examine translation in the islet  cell 
using techniques to measure ribosomal occupancy of total RNA as well as 
specific RNAs under conditions of diabetes relevant stressors.  They 
demonstrate that physiological models of ER stress result in global translation 
initiation shut down, as well as translational activation of specific stress 
remediating transcripts.  Interestingly, changes to ribosomal occupancy of 
specific messages is evident prior to general translation shut down in the case of 
cytokine treatment, suggesting early activation of important stress remediating 
translational mechanisms in the setting of diabetes. 
 A key objective of these studies was to investigate mechanisms regulating 
Pdx1 translation in the islet  cell.  Pdx1 is a protein of critical importance to the  
cell, as it is necessary for  cell development and for the normal function of 
mature  cells.  It has also been shown to play a key role in  cell ER stress 
remediation, as it appears to function as a transcriptional activator of genes 
important for ER homeostasis including Atf4, Wfs1, and Ero1b, and 
haploinsufficiency of Pdx1 in mice predisposes animals to ER stress and  cell 
apoptosis (13,32).  Previously, we showed that in the setting of type 1 diabetes in 
the NOD mouse, failure to maintain Pdx1 protein levels in the  cell may be a 
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contributing factor to the increasing ER stress and  cell dysfunction seen in that 
model (41).   
 Our studies here are the first to provide important insight into a potential 
mechanism whereby Pdx1 mRNA translation is maintained at elevated levels 
during ER stress despite global suppression of translation initiation.  Our studies 
identified that a discrete region of the 5’-UTR of the mouse Pdx1 mRNA has 
properties that enhance translation of downstream coding regions.  Using a 
bicistronic reporter vector, I showed that the region between –105 and –280 is 
able to independently drive reporter gene translation, whereas the region 
between -1 and –104 and the 5’-UTR of Cpe are unable to do so.  Importantly, 
the homologous regions of the human PDX1 gene retained similar properties, 
suggesting that the phenomenon may be applicable to humans.   
 The mechanisms driving translation of mRNAs during stress have been 
studied for a number of genes, and include such phenomena as internal 
ribosome entry sites (IRESs) and upstream open reading frames (uORFs).  
uORFs have been estimated to occur in up to 40% of transcripts (142), but 
whether such elements function in a regulatory manner requires experimental 
verification.  I identified that conserved uORFs (with AUGs at postions –171 and 
–213) exist in the mouse and rat Pdx1 5’-UTR, with AUG occurring at position –
171 being conserved with humans.  Deletion of a proximal region of this uORF 
(DM1) did not affect reporter activity.  Further, we did not observe changes to 
Pdx1 ribosomal occupancy similar to that of mRNAs known to be regulated by 
upstream open reading frames (Atf4, Chop).  These findings suggest regulatory 
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mechanisms other than uORFs contribute to 5’ UTR mediated stress resistant 
translation of Pdx1.   
 IRESs are a heterogeneous group of elements found in the 5’ UTR of viral 
and cellular mRNAs which allow end-independent recruitment of ribosomes for 
translation initiation (137,141).  It is believed that secondary structure in IRESs 
allows recruitment of translation initiation factors and ribosomal components 
necessary for the internal assembly of competent ribosomes (137).  IRESs have 
been identified as regulatory elements in other  cell mRNAs including Bip and 
Xiap (148,186).  Interestingly, the Pdx1 5’ UTR contains ~75% G-C content, and 
significant predicted secondary structure, suggestive of IRESs elements.  Further 
studies are required to determine the precise mechanism of action of this 
regulatory element. 
 Taken together, our findings shed new light on mechanisms to maintain 
Pdx1 protein synthesis under conditions of stress, which is critical to  cell well-
being.  While the Pdx1 mRNA 5’ UTR confers cap-independent translation 
compared to controls, it is important to note this activity was reduced under 
conditions of stress, particularly in the case of cytokine treatment.  Thus, it is 
feasible that failure of cap-independent Pdx1 translation in the setting of diabetes 
contributes to  cell dysfunction and death.  Although not directly tested in this 
study, it is also conceivable that regulation of Pdx1 mRNA translation by its 5’-
UTR may also be important during pancreas development since cellular 
differentiation might also be considered a form of cellular stress.  Pdx1 mRNA 
exhibits unique properties under stress that contribute to its ongoing translation.  
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A better understanding of the mechanisms involved in Pdx1 translation—such as 
the factors that may promote Pdx1 mRNA translation via its 5’-UTR—could lead 
to therapies aimed at preserving Pdx1 expression and  cell function in diabetic 
states (Fig. 19).  
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Figure 19: Regulation of translation initiation during the  cell UPR.    cell 
stressors including proinflammatory cytokines, free fatty acids, and high insulin 
demand lead to ER stress and the UPR.  During this response, a new program of 
translational control prevails, which suppresses translation initiation of a number 
of transcripts, while allowing translational activation of other transcripts, while still 
other transcripts are translationally resistant to such stress.  Together, these 
translational responses work to remediate ER stress and restore  cell 
homeostasis. 
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CHAPTER 4 
Deoxyhypusine Synthase Haploinsufficiency Attenuates  
Acute Cytokine Signaling 
 
 In this chapter, I investigate the role of deoxyhypusine synthase in 
development, proliferation, glucose homeostasis, and translation of stress-
specific  cell transcripts.  Whole-body Dhps knockout mice provided a model of 
genetic DHS deficiency that was used to validate studies using a small molecule 
inhibitor of DHS.  Mouse phenotyping experiments were done in collaboration 
with Dr. Sarah Tersey at Indiana University School of Medicine.     
 
4.1 INTRODUCTION 
 Deoxyhypusine synthase (DHS) catalyzes the post-translational formation 
of the amino acid hypusine.  Hypusine is unique to the eukaryotic translation 
initiation factor 5A (eIF5A), and is required for its functions in mRNA shuttling, 
translational elongation, and stress granule formation.  In recent studies, we 
showed that DHS promotes acute cytokine and ER stress signaling in the islet  
cell, thereby contributing to its dysfunction in the setting of diabetes mellitus 
(133,162).  Because many of the previous studies of DHS involved small 
molecule inhibitors of the enzyme, such as GC7, I chose to investigate 
developmental and metabolic phenotypes associated with genetic DHS loss of 
function mutation, using conventional, whole body, DHS knockout (KO) mice.  
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Additionally, I investigated consequences of genetic DHS deficiency in Dhps 
knockout MEFs.  
 
4.2 RESULTS 
A. Dhps heterozygosity does not alter growth or metabolic homeostasis 
 Fig. 20A shows our Dhps gene targeting strategy.  Exons 1-7 were 
replaced by a neomycin selection cassette, preserving exons 8 and 9 (exon 9 
contains a gene, Wdr83, on the reverse strand).  This strategy ensures that no 
elements containing the catalytic or binding domain of the DHS protein are 
produced.  Using this targeting strategy, mice harboring a Dhps knockout allele 
(Dhps+/-) were generated on a mixed C57BL6/129SvEv genetic background.  
Based on the analysis of offspring from 20 separate matings between Dhps+/- 
mice (total of 99 offspring), I have obtained 34 Dhps+/+ mice, 65 Dhps+/- mice, 
and no Dhps-/- mice.  Given the expected Mendelian ratio of 2:1 for Dhps+/-
:Dhps+/+ mice, and the absence of Dhps-/- mice, I conclude that the Dhps-/- 
genotype is embryonic lethal.  I subsequently analyzed embryos from an 
additional 3 pregnancies at embryonic day 8.5-9.5, but was unable to identify any 
Dhps-/- embryos.  I next focused on the phenotype of Dhps+/- mice.  As shown in 
Fig. 20B-D, there is no difference between Dhps+/+ and Dhps+/- mice with 
respect to body weight as mice age from 5-25 weeks, or in glucose homeostasis 
at 5 and 25 weeks of age (as assessed by intraperitoneal glucose tolerance tests 
(IPGTTs)).  
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Figure 20: Dhps heterozygosity does not alter growth or metabolic 
homeostasis in mice.  A, schematic diagram of the Dhps gene targeting vector 
(KO), and the wild type mouse locus (WT).  Dotted lines represent homologous 
recombination regions. Neo, neomycin selection cassette; B, serial body weights 
of Dhps +/+ and Dhps +/- mice between 5-25 weeks of age; C, results of glucose 
tolerance tests in mice at 5 weeks of age; D, results of glucose tolerance tests in 
mice at 25 weeks of age.  
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B. Dhps heterozygosity attenuates acute cytokine signaling in mouse 
embryonic fibroblasts 
 Although the growth and metabolic characteristics of Dhps+/- mice appear 
unaffected, they do not rule out the possibility that reductions in DHS protein may 
still lead to phenotypic differences under conditions of stress.  As an initial 
approach to address this possibility, I isolated mouse embryonic fibroblasts 
(MEFs) from Dhps+/+ and Dhps+/- embryos at embryonic day 13.5.  Compared 
to Dhps+/+ MEFs, Dhps+/- MEFs contain approximately 50% less DHS protein 
as assessed by immunoblot analysis (Fig. 21A).  The hypusine reaction can be 
monitored by polyacrylamide gel electrophoresis after incubating cells with the 
radiolabelled cofactor 3H-spermidine (see Chapter 2.2E).  Although total eIF5A 
protein is unchanged between Dhps+/+ and Dhps+/- MEFs, the rate of 3H-
spermidine incorporation into eIF5A is reduced by approximately 40% in Dhps+/- 
MEFs (Fig. 21B), a finding consistent at the protein level with haploinsufficiency 
of Dhps at the genetic level.  To assess the response of haploinsufficient cells to 
the type of stress observed in diabetes, I subjected MEFs to incubation with a 
cocktail of proinflammatory cytokines (IL-1, TNF-, and IFN-) for 4h.  In prior 
studies, I showed that proinflammatory cytokines cause acute induction of the 
mRNA and protein for iNOS, and that inhibition of DHS with GC7 blocks 
expression of iNOS protein, but not its mRNA (133).  As shown in Fig. 21C and 
D, activation of the mRNA encoding iNOS (Nos2) is unaffected in Dhps+/- MEFs, 
but the production of iNOS protein is reduced by 60%.  Although these data are 
not direct evidence of translational control of Nos2 mRNA, the dissociation 
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between the mRNA levels and protein levels are nonetheless suggestive.  These 
findings align with prior studies, and verify at the level of Dhps haploinsufficiency 
what we observed in vitro and in vivo with DHS inhibitors (133).   
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Figure 21: Dhps heterozygosity attenuates acute cytokine signaling in 
mouse embryonic fibroblasts.  A, immunoblot analysis for DHS and actin from 
whole cell extracts of Dhps +/+ and Dhps +/- MEFs (top panel), and quantification 
of DHS protein levels (bottom panel); B, MEFs were incubated with 1?Ci 3H-
spermidine for 4h, then subjected to immunoblot analysis of eIF5A and actin, or 
to fluorography for 3H-eIF5A following SDS-PAGE (top), and 3H-eIF5A was 
quantified (bottom); C, MEFs were incubated in the presence or absence of 
cytokines for 4h, then cDNA was subjected to qRT-PCR for Nos2; D, immunoblot 
analysis of iNOS and actin from whole cell lysates of MEFs treated with or 
without cytokines for 4h (top), and quantification of iNOS expression (bottom).  
Data represent mean ± SEM.  n3.  *P<0.05 compared to empty vector. 
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C. Dhps heterozygosity does not lead to significant inhibition of 
proliferation and G1/S cell cycle progression 
 To address the possibility that inhibition of DHS leads to defects in cellular 
proliferation, I performed 3H-thymidine uptake studies in MEFs.  As shown in Fig. 
22A, Dhps+/- MEFs demonstrated a roughly 40% lower 3H-thymidine uptake over 
a 4h period compared to Dhps+/+ cells, although this difference did not strictly 
reach statistical significance (p=0.06).  This reduction in cellular proliferation in 
Dhps+/- cells correlated to a small, but again statistically insignificant, increase in 
the proportion of cells in G1 phase and a decrease in the proportion of cells in 
the S phase, a finding consistent with trend to G1/S block (Fig. 22B).   By 
contrast, under cytokine stress conditions, no obvious differences in proliferation 
or cell cycle populations were observed between the two genotypes (Fig. 22C 
and D).  Overall, however, the lack of statistically significant changes in cell cycle 
populations is consistent with the observation that Dhps+/- mice displayed no 
obvious differences in growth or weight up to 6 months of age. 
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Figure 22: Dhps heterozygosity does not lead to significant inhibition of 
proliferation and G1/S cell cycle progression.  A, MEFs were incubated with 
15Ci 3H-methyl thymidine for 4h, then washed and lysed.  3H-thymidine 
incorporation was measured and normalized to protein content; B, MEFs were 
incubated with Guava cell cycle reagent for 30 min, and intercalation of 
propidium iodide into cellular DNA was quantified using FACS; C, same as in A, 
except cells were treated concurrently with cytokines and 3H-methyl thymidine for 
4h; D, same as B, except cells were treated with cytokines for 4h prior to 
incubation with Guava reagent.  Data represent mean ± SEM.  n3.  *P<0.05 
compared to empty vector. 
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4.3 DISCUSSION 
 Prior studies have pointed to a potential role for DHS and hypusinated 
eIF5A in the responses of islet  cells to proinflammatory and ER stressors.  
Given the totality of the data on the two proteins, it is fair to ask how precisely 
this pair should be viewed with respect to cellular survival.  On one hand, 
depletion of eIF5A or inhibition of DHS appears to be beneficial, preventing 
hyperglycemia in mouse models of inflammation-induced diabetes (133,162); in 
another particularly striking study, depletion of eIF5A protects mice against death 
in the setting of sepsis induced by lipopolysaccharide (187).  On the other hand, 
inhibition of DHS or depletion of eIF5A can also have negative effects, leading to 
defects in both cell cycle progression and the formation of stress granules (159).  
Further, I show that Dhps-/- mice are early embryonic lethal.   Thus, it is possible 
that DHS is important either in the proliferation of early embryonic cells and/or in 
the ability of those cells to activate stress signaling pathways during 
differentiation. 
 With respect to the islet  cell, it may be best to view DHS and eIF5A as 
representing stress-responsive proteins whose functions are accentuated in 
periods of acute stress (such as inflammation, viral infection, sepsis, etc.).  Under 
these stress conditions, I propose that DHS and eIF5A are necessary for 
regulating the ultimate translation of proteins that are involved in stress 
remediation or adaptation; however, as the stress continues unabated, these 
proteins may be required to trigger the cellular execution response in an attempt 
to limit the extent of stress.  Thus, DHS and eIF5A may regulate the balance 
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between adaptive and pro-death responses in the cell.  As such, it is possible 
that too much or too little of these proteins may shift the balance in favor of 
cellular death.  The db/db mouse model may represent a particularly dramatic 
example of this balance in the islet:  the C57BL/6J-db/db strain attenuates eIF5A 
hypusination rates sufficiently to favor islet adaptation and normoglycemia, 
whereas the C57BKLS/J-db/db strain maintains hypusination rates that favor islet 
death (162).   
Hypusination may be an attractive therapeutic target in the islet  cell for 
several reasons. First, hypusinated eIF5A has a very short half-life in islets (~6 h) 
compared to other cell types (>20 h) (133,188–190), a finding supporting an 
acute regulatory role for the protein in islets.  Also, eIF5A and DHS exhibit rapid 
and reciprocal nucleo-cytoplasmic shuttling in  cells in response to cytokines or 
ER stress (133,162), whereas in other cell types specific compartmentalization is 
less clear or controversial (168,191).  Finally, the islet  cell has a very slow 
replicative rate and therefore is less susceptible acutely to agents (such as DHS 
inhibitors) that affect cellular proliferation. 
Our data suggest that Dhps+/- mice can maintain normal growth and 
glucose homeostasis (Fig. 20), and that their cells attenuate responses to 
inflammation.  Indeed, Dhps +/- MEFs exhibit reduced iNOS protein expression 
in response to cytokine exposure compared to wild type controls (Fig. 21), a 
result that supports our findings using the pharmacological DHS inhibitor GC7.  
In these respects, I believe pharmacologic approaches to inhibiting DHS may be 
successful in mitigating diabetes progression in animal models.  Nonetheless, 
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further research using islet and   cell-specific knockout mouse models of DHS 
and eIF5A will be especially helpful in elucidating the roles of these proteins in 
islet cell types and diabetes models. 
 Recent work has suggested that hypusinated eIF5A functions to alleviate 
ribosome stalling at specific amino acid sequences, including polyproline motifs 
(138,139).  Therefore, DHS and eIF5A may be necessary for efficient translation 
of a subset of transcripts within the cell, and eIF5A hypusination may represent 
an important mechanism of translational regulation.  Although studies of the 
function of hypusinated eIF5A provide interesting insight into the precise 
mechanism of eIF5A, as well as potential targets, further studies are required to 
reveal the physiological significance of this system with regards to diabetes. 
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CHAPTER 5 
Translational Control of Inducible Nitric Oxide Synthase by  
p38 MAPK in Islet  Cells 
 
 Given the role of deoxyhypusine synthase in translational of specific 
mRNAs, we next investigated how DHS activity is regulated.  In this chapter, I 
explore the role of MAPKs in translational regulation of iNOS, and suggest a role 
for p38 signaling in deoxyhypusine synthase activation in the  cell.  Mechanisms 
of DHS and p38 facilitated iNOS translation are explored.  Immunoblot and 
fluorography studies were done in collaboration with Dr. Yurika Nishiki at Indiana 
University School of Medicine. 
 
5.1 INTRODUCTION  
 The mitogen-activated protein kinases (MAPKs) are transducers of 
extracellular signals, such as proinflammatory cytokines.  In islet  cells, 
cytokines acutely activate expression of the Nos2 gene encoding inducible nitric 
oxide synthase (iNOS), which ultimately impairs insulin release.  Because Nos2 
can also be regulated post-transcriptionally, we asked if MAPKs participate in 
events following Nos2 transcription in  cells and primary islets.  DHS and eIF5A 
are believed to be necessary for translation of a specific subset of  cell stress 
responsive transcripts, including Nos2.  However, relatively little is known about 
how expression of hypusinated eIF5A is regulated in response to stress in the  
cell, and how this affects translation.  Therefore, we undertook experiments to 
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explore the relationship between MAPK signaling, DHS activity, and iNOS protein 
expression. 
 
5.2 RESULTS 
A. Inhibition of p38 partially blocks iNOS protein production.  
 Prior studies have shown that p38 inhibition partially blocks activation of 
the gene encoding iNOS (Nos2) within the 24h timeframe following cytokine 
exposure (192).  Fig. 23A and B show that in the timeframe of our studies (4h), 
there was no significant effect of p38 inhibition by PD169316 on the activation of 
Nos2 in INS-1  cells or rat islets.  The same result was true of inhibition of the 
MAPK c-Jun N-terminal kinase (JNK) by SP006125 (Fig. 23A and B).  Next we 
examined the effect of p38 inhibition by PD169316 on cytokine-induced iNOS 
protein levels by immunoblot.  As shown in Fig. 23C and D, p38 inhibition 
attenuated cytokine-induced iNOS protein expression by ~40% in INS-1 cells and 
by ~50% in rat islets compared to controls.  By contrast, inhibition of the MAPK 
JNK with SP600125 did not affect iNOS protein levels (Fig. 23C and D).  
Whereas cytokines enhanced the phosphorylation of p38 in INS-1 cells, inhibition 
of p38 blocked its own phosphorylation (Fig. 23C)—a finding consistent with 
known effects of p38 inhibitors.  The results in Fig. 23 suggest that p38 activity 
enables a post-transcriptional process that maintains normal iNOS protein levels, 
reminiscent of the role of DHS in iNOS translation.   
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Figure 23: Effect of enzyme inhibitors on cytokine-induced Nos2 mRNA and 
iNOS protein expression.  A, INS-1 rat  cells, and B, rat islets were untreated, 
or treated with cytokines for 4h in the presence or absence of the indicated 
inhibitors, cells were harvested and cDNA was subjected to qRT-PCR for Nos2 
message.  Data corrected for Actb mRNA, and compared to untreated control; C, 
INS-1  cells, and D, rat islets were untreated, or treated with cytokines for 4h in 
the presence or absence of the indicated inhibitors, then whole cell lysates were 
subjected to immunoblot analysis of protein expression.  Data corrected for actin 
expression and quantified.  Data represent mean ± SEM.  n=3.  *P<0.05 
compared to untreated control (A, B), or cytokine-only control (C, D). 
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B. p38 and DHS activity promote translational elongation of Nos2 mRNA  
 The data in Fig. 23 suggest that p38 activity contributes to translation of 
Nos2 mRNA.  To interrogate more directly the possibility that p38 activity is 
required for Nos2 translation, I performed polyribosome profile (PRP) analysis 
using INS-1  cells.  INS-1 cells were incubated with cytokines in the absence or 
presence of inhibitors of translational initiation (thapsigargin, Tg), translational 
elongation (cycloheximide, CHX), p38 (PD169316), JNK (SP600125), and DHS 
(GC7).  Fig. 24A shows the INS-1 cell PRP after 4h of cytokine incubation, 
identifying the positions of the 40S, 60S, 80S ribosome-associated RNA, as well 
as the position of polyribosome associated RNA.  Co-incubation with cytokines 
and Tg resulted in a dramatic enhancement to monoribosome- and diribosome-
associated RNA and near-complete dissipation of polyribosome-associated RNA 
(Fig. 24B), consistent with a block of translation initiation.  Importantly, the Nos2 
mRNA, which is associated primarily with actively translating polyribosomes 
under cytokines conditions, shifts leftward toward the monoribosome-associated 
fractions in the presence of Tg (Fig. 24B, shaded region), indicative of translation 
initiation blockade of Nos2.  By contrast, incubation with CHX leads to increases 
in both monoribosome- and polyribosome-associated RNAs, findings that 
reflecting a block in translational elongation (Fig. 24C).  In this case, Nos2 mRNA 
is retained in the polyribosome fractions.  When INS-1 cells are treated with p38 
and JNK inhibitors, there remains retention of polyribosome-associated RNAs, 
comparable to that seen with CHX (Fig. 24D and E).  Treatment with the DHS 
inhibitor GC7 results in a PRP similar to the MAPK inhibitors, but with greater 
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monoribosome and diribosome-associated RNAs (Fig. 24F).  Similar to CHX 
treatment, the Nos2 mRNA remains largely associated with polyribosomes in the 
setting of MAPK and DHS inhibition (Fig. 24D-F, shaded region), suggesting that 
this mRNA is translationally blocked at the elongation phase. 
 To clarify whether p38 promotes translational elongation specifically in the 
setting of cytokine stress, I next performed PRP studies using p38 +/+ and p38 
-/- MEFs.  As shown in Fig. 25A, comparison of the PRP of p38 +/+ MEFs to 
that of p38 -/- MEFs revealed an accumulation of polyribosome associated 
RNAs in the p38 -/- MEFs, suggestive of a translation elongation blockade.  
After p38 +/+ MEFs were incubated with Tg for 4h (Fig. 25B), there is 
prominence of the 80S peak (reflective of a translation initiation block caused by 
Tg).  In contrast to p38 +/+ cells, p38 -/-  cells exhibit greater retention of 
polyribosome-associated RNAs upon treatment with Tg (Fig. 25B, right panel), 
again suggesting that the absence of p38 results in a partial defect in 
translational elongation.  Thus, I conclude that p38 promotes translational 
elongation, and suggest a link between p38 and hypusinated eIF5A. 
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Figure 24:  Effect of enzyme inhibitors on Nos2 mRNA ribosomal 
occupancy.  INS-1  cells were cultured with cytokines for 4h in the presence or 
absence of the indicated inhibitors, then subjected to PRP analysis with 
fractionation of the sedimentation gradient, and analysis of Nos2 mRNA in PRP 
fractions.  Cells were treated with A, cytokines alone, B, cytokines plus 
thapsigargin, C, cytokines plus CHX, D, cytokines plus p38 inhibitor, E, cytokines 
plus JNK inhibitor, F, cytokines plus DHS inhibitor.  Closed circles encompassing 
shaded areas illustrate the distribution of Nos2 mRNA.  Data shown are 
representative profiles obtained from 3-4 independent experiments. 
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Figure 25: p38 activity promotes translational elongation.  A, p38+/+ MEFs 
(left panel) and p38-/- MEFs (right panel) were treated with cytokines for 4h, and 
then subjected to PRP; B, p38+/+ MEFs (left panel) and p38-/- MEFs (right panel) 
were treated with cytokines plus 10M Tg for 4h, and then subjected to PRP.  
Shaded area indicates polyribosome region.  P/M ratio values are shown for 
each profile. 
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C. p38 activity contributes to eIF5A hypusination 
 These results point to a role for p38 activity in Nos2 translational 
elongation that appears similar to that of DHS, an enzyme that is required for the 
function of eIF5A (133).  We therefore asked whether the apparent translational 
effect of p38 might be related directly to the function of eIF5A.  The translational 
elongation function of eIF5A is dependent upon the hypusine modification of 
Lys50, a reaction that is sequentially catalyzed by DHS and deoxyhypusine 
hydroxylase (164).  DHS activity can be measured directly by 3H-spermidine 
incorporation into eIF5A (see Chapter 2.2E). As anticipated, INS-1  cells, rat 
islets, and human islets treated with the DHS inhibitor GC7 exhibited a disruption 
in eIF5A hypusination (Fig. 26A-C) (193).  Whereas the JNK inhibitor SP600125 
had no significant effect on hypusine incorporation, the p38 inhibitor PD169316 
caused a significant decrease in hypusination in both the  cell line and primary 
rat and human islets in the presence of cytokines (Fig. 26A-C).  Interestingly, no 
effect of p38 inhibition on hypusine incorporation was observed in the absence of 
cytokines, implying an effect of p38 that is cytokine dependent.  Taken together, 
these data indicate that p38 MAPK promotes activity of DHS in the presence of 
cytokine signaling, leading to enhanced translational elongation of Nos2 mRNA. 
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Figure 26: Effect of enzyme inhibitors on eIF5A hypusination.   A, INS-1  
cells, B, rat islets, or C, human islets were exposed to 3H-spermidine for 4h in the 
presence or absence of cytokines and the indicated inhibitors, then whole cell 
extracts were harvested and subjected to SDS-PAGE and fluorography for 
hypusinated eIF5A (3H-eIF5AHyp) or immunoblotting for total eIF5A and actin.  
Panels on the left show representative fluorography and immunoblots, while 
panels on the right show quantification of hypusinated eIF5A normalized to actin.  
Data represent mean ± SEM.  n=3.  *P<0.05 compared to cytokine only control.      
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5.3 DISCUSSION 
Proinflammatory cytokines have been implicated in the pathogenesis of 
islet  cell dysfunction in both type 1 and type 2 diabetes mellitus, and potential 
therapies targeted against cytokines or their signaling pathways have been 
proposed as approaches to preserve  cell function and survival in both 
diseases.  The MAPKs have been suggested as therapeutic targets in the setting 
of diabetes because their actions downstream of cytokine signaling promote both 
transcription and translation of mRNAs that contribute to the dysfunction or death 
of a variety of cell types that regulate metabolic homeostasis (for review, see ref. 
(194)).  Our studies suggest a novel mechanism whereby MAPKs, specifically 
p38, support the translational elongation of Nos2 mRNA via hypusination of the 
translational factor eIF5A. 
Polyribosomal profiling experiments using INS-1  cells revealed that 
Nos2 mRNA remained associated with polyribosomes in the setting of p38 
inhibition, in a manner similar to that seen with blockade of translation elongation.  
Consistent with a role in translation elongation, p38 activity contributes to 
hypusination of eIF5A.  Our results suggest a novel signaling pathway in which 
p38 MAPK promotes translation elongation of Nos2 mRNA via regulation of 
eIF5A hypusination. 
Translational elongation at the ribosome is dependent upon the interplay 
of a group of translational factors that are distinct from those involved in the 
initiation of translation (reviewed in ref. (150)).  Interestingly, the translation factor 
eIF5A was originally identified as an initiation factor based on early studies of in 
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vitro methionyl-puromycin synthesis (195).  In the intervening years, its role as an 
initiation factor has been questioned and more recent studies suggest it functions 
primarily as an elongation factor (139,158).  Nevertheless, controversy still exists 
in the literature as to whether eIF5A functions primarily as an initiation or 
elongation factor (196).   
The post-translational hypusine modification of eIF5A is required for the 
known translational and RNA binding functions of eIF5A (164).  In recent studies 
we demonstrated that hypusinated eIF5A is required for nuclear export and 
translation of Nos2 mRNA in  cells (133).  Here, we show that p38 inhibition 
leads to reduced hypusination in the setting of cytokine signaling, resulting in 
reductions in iNOS protein that parallel effects observed with inhibition of DHS.  
Although both DHS and DOHH contain putative MAPK phosphorylation sites, I 
should note that our data do not necessarily imply that p38 directly modifies 
(phosphorylates) either protein.  Studies currently ongoing will evaluate the 
possibility that direct phosphorylation of DHS by p38 may be necessary for the 
activity and/or stability of DHS. 
Taken together, our data suggest a pathway whereby p38 activity links, in 
part, the transduction of cytokine signals with activation of hypusination. Although 
I cannot rule out the possibility that other translational elongation factors, such as 
eEF2, also participate in the translational elongation of Nos2 promoted by p38, it 
is possible that these factors are all linked closely to one another such that loss 
in the activity of one can affect the assembly of the full translational elongation 
complex.  In the case of eIF5A, the factor does not appear to function as a 
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generalized translational factor, but instead promotes the elongation of only a 
subset of mRNAs in the  cell (133,158,159).  Thus, our observations in this 
study may represent a novel p38-linked translational pathway for specific stress 
responsive transcripts.  A limitation in these studies is the use of small molecule 
inhibitors, although the concern for off-target effects is mitigated by our parallel 
findings in p38 -/- MEFs.   Nevertheless, because such inhibitors may find their 
way into the clinical settings of type 1 and type 2 diabetes, our studies provide 
new insight into the mechanisms by which MAPK inhibition might limit the 
consequences of inflammation on the islet  cell. 
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Figure 27: Role of DHS and eIF5A in the  cell stress response.  DHS and 
eIF5A are interrelated proteins necessary for efficient translational elongation of 
a number of  cell transcripts.  Current reports indicate hypusine-eIF5A is 
involved in translational elongation of both stress remediating and death inducing 
factors (133,162).  Therefore, the cellular balance of hypusinated eIF5A may be 
key in determining  cell fate.  
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CHAPTER 6 
Conclusions 
 
 Failure of the islet  cell is now recognized as the major event leading to 
onset of diabetes (2).  Thus, a greater understanding of  cell dysfunction and 
death is critical to devising new treatments for preservation of  cell function, and 
to preventing diabetes.  Whereas  cell transcriptional responses to stress are 
well understood, less is known about  cell translational responses, and how 
these may mitigate, or contribute to  cell dysfunction.    
  
6.1 REGULATION OF  CELL TRANSLATION INITIATION 
 In the studies outlined here, I have investigated translational stress 
responses of the pancreatic  cell.  First, I determined that chronic treatment of  
cells with proinflammatory cytokines or palmitate results in loss of polyribosome 
associated RNAs, consistent with attenuation of translation initiation, which is a 
feature of ER stress.  This loss of polyribosome associated RNA coincided with 
decreased total protein synthesis, further suggesting ER stress in these models.  
In addition to changes in general translation status, I observed transcript specific 
regulation of ribosomal occupancy in  cells.  Atf4 and Chop are translationally 
activated by proinflammatory cytokine or Tg treatment in the  cell,  whereas Cpe 
is translationally repressed.  Interestingly, ribosomal occupancy of Pdx1 mRNA 
did not change under any of the conditions I studied, indicating it is translationally 
regulated by a distinct mechanism.  Further studies identified a regulatory region 
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in the Pdx1 5’ UTR that allows maintenance of translation initiation in the setting 
of the UPR.   
 Although more studies are required to fully understand the mechanism of 
stress resistant Pdx1 translation, my experiments identify the region from 
nucleotides -105 to -280 of the Pdx1 5’ UTR as a positive regulator of translation 
initiation.  A better understanding of the factors allowing operation of this 
mechanism may shed light into causes of decreased Pdx1 expression in 
diabetes, or alternatively, provide new ways to enhance Pdx1 expression in the 
islet  cell, thereby improving  cell function.   Therefore, a greater understanding 
of Pdx1 translation initiation will lead to therapies designed to promote Pdx1 
expression, thus maintaining i cell identity and function, and preventing diabetes. 
  
6.2 REGULATION OF  CELL TRANSLATION ELONGATION 
 In addition to studying mechanisms of translation initiation in the  cell, I 
also studied the roles of DHS and eIF5A in  cell translational elongation.  Initial 
experiments with whole body Dhps knockout mice demonstrated that the Dhps -/-  
genotype is embryonic lethal before day E9.5.  In contrast, Dhps +/- mice 
appeared metabolically healthy, with normal weight and glucose tolerance 
between 5 and 25 weeks of age.  Additionally, MEFs isolated from Dhps +/- mice 
displayed reduced DHS protein expression and activity, and attenuated cytokine 
induced iNOS expression compared to wild type MEFs.  This reduction in iNOS 
expression is mediated post-transcriptionally.   
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 These data provide insight into the role of DHS in development, and 
support at the genetic level experiments carried out using small molecule DHS 
inhibitors.  Specifically, these experiments demonstrate the importance of DHS in 
cytokine induced Nos2 translation.  Given the hypothesized role of DHS in 
allowing translation of specific stress responsive mRNAs, DHS inhibition may 
represent a  inhibition may represention  Indeed, DHS inhibition results in 
reduced Nos2 translation and improved glucose tolerance in mouse models of 
diabetes (165).  However, a greater knowledge of the translational targets of 
hypusinated eIF5A is needed to fully grasp the physiological outcomes of  cell 
DHS inhibition.  Ongoing studies of pancreas and  cell specific Dhps knockout 
mice will be critical to our understanding of the role of DHS in  cell translational 
responses. 
 In addition to investigating targets of DHS and eIF5A, I was also interested 
in understanding how DHS activity is regulated in response to stress.  In this 
regard, we investigated the roles of the MAPKs p38 and JNK in eIF5A 
hypusination and cytokine induced iNOS expression.  Similar to DHS inhibition, 
we determined that p38 inhibition resulted in attenuated cytokine induced iNOS 
expression, and that this reduction was not due to differences in Nos2 mRNA 
abundance.  Next, using PRP, I demonstrated that both DHS inhibition and p38 
inhibition result in an apparent block of Nos2 translational elongation.  
Interestingly, p38 -/- MEFs displayed increases in polyribosome associated 
RNAs, also suggestive of a role for p38 in translational elongation.  Finally, we 
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demonstrated that inhibition of p38 results in decreased DHS activity, as 
assessed by 3H-spermidine incorporation.   
 These data suggest a role for p38 in translational elongation of Nos2 
mRNA, possibly via induction of DHS activity.  As such, p38 inhibition may 
represent another therapeutic strategy for maintenance of  cell function.  
Although the effects of p38 inhibition on Nos2 mRNA translation are similar to 
those of DHS inhibition, our studies do not necessarily imply a direct activation 
(phosphorylation) of DHS by p38.  Future studies exploring direct 
phosphorylation of DHS by p38 will add significantly to knowledge of stress 
induced regulation of DHS activity. 
 
6.3 FINAL THOUGHTS 
 Islet  cell research has demonstrated that loss of  cell function is the key 
determinant in development of both type 1 and type 2 diabetes (42,59).   cell 
translational regulation, which is a consequence of inflammation, ER stress, and 
the UPR, represents a novel area of research for development of therapeutics 
targeted at improving  cell function.  Translational regulation in the islet  cell is 
an important determinant in continued  cell function and health (129,197).  
Thus, continued research into  cell translation regulatory mechanisms are vital 
for addressing the problem of  cell dysfunction in diabetes.  Ultimately, 
exploitation of mechanisms of  cell translational regulation including 5’ UTR 
mediated Pdx1 translation initiation and DHS facilitated Nos2 translation 
elongation will lead to therapeutics for improved  cell function and survival.  
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